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A NOTE FROM ROSS HALL

BUILDING
A STRONG
FOUNDATION

I

n the pages of this edition of Medicine + Health, you will
recognize that much is happening at the GW School
of Medicine and Health Sciences (SMHS). Since the
beginning of the year, when we published the new
strategic plan for SMHS, we have established the impetus for
momentum and growth in key strategic areas. The first goal of
our strategic plan focuses on leadership — that is, to promote
a culture of excellence through leadership, performance
improvement, professionalism, and diversity and inclusion for
students, residents, faculty, and staff.
Over the past few months, we have welcomed many new
faces to our roster of leaders. Some of these leaders are dedicated
to the fight against cancer, such as Eduardo Sotomayor, M.D.,
who has been tapped to lead the GW Cancer Center, and Ed
Seto, Ph.D., who will lead basic science efforts for the center.
Cancer research and clinical care will continue to be an
important target for growth and will continue to evolve under
Dr. Sotomayor’s leadership. I encourage you to support our
efforts as we build aggressively in this area.
In addition, SMHS has appointed three new chairs. In
September, we welcomed nationally recognized Raj Rao, M.D.,
as the new chair of the Department of Orthopedic Surgery. In
the Health Sciences, we selected Margaret Plack, Ed.D., DPT,
PT, to lead the innovative and entrepreneurial Department of
Clinical Research and Leadership; and Karen Wright, Ph.D.,
PA-C, to lead the highly regarded Department of Physician
Assistant Studies. In the M.D. program, we have continued
to build out our leadership team under Richard Simons,
M.D., senior associate dean for M.D. programs, by welcoming
Katherine Chretien, M.D., as the new assistant dean for student
affairs.
You will read about each one of these new leaders in the
pages of this magazine. We are very excited to have such a breadth
of talent and expertise leading this great institution.
Sincerely,

JEFFREY S. AKMAN, M.D. ’81, RESD ’85
VICE PRESIDENT FOR HEALTH AFFAIRS
WALTER A. BLOEDORN PROFESSOR OF ADMINISTRATIVE MEDICINE
DEAN, SCHOOL OF MEDICINE AND HEALTH SCIENCES

NELSON A. CARBONELL, B.S. ’85
Chair, Board of Trustees
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TO THE EDITOR,
I attended this evening’s (June 9)
Frontiers in Medicine lecture sponsored by GW’s School of Medicine and
Health Sciences. At the check-in table,
there were issues of the latest Medicine
+ Health magazine. The cover picture
of Jehan “Gigi” El-Bayoumi, M.D.,
immediately caught my eye. I count
Dr. El-Bayoumi as a friend. She was my
mother’s internist from late 2005 to her
death in September 2014.
I first met Dr. El-Bayoumi through
another friend, Marie Borum, M.D.
She was immediately friendly and
seemed like a good person to know.
In 2005 my mother had a stroke. For a
week she stayed in Harper Hospital in
Detroit, where she lived. I contacted
Gigi from Detroit, explained the situation, and asked her to take my mother
as a patient when we returned to
Washington, D.C.

Gigi provided my mother with
excellent care. She was always compassionate, never rushed (even when
busy), and she always explained things
to my mother in a way she could
understand. Gigi gave my mother the
same level of care that she would have
wanted for her mother.
There were occasions when Mom
needed to be seen by specialists. The
doctors that Gigi referred us to were
excellent. They all worked together so
that Mom got the best care — particularly in late 2011 when she became
anemic, began to lose weight, and
ultimately was diagnosed with multiple
myeloma. From then until the summer
of 2014, we saw many GW doctors, and
Mom had a great medical team.
Last summer, Gigi saw Mom for
the last time. It was clear to both of
us that my mother was failing. I had
some end-of-life questions, and Gigi
answered them forthrightly and with
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HEALTH EQUITY
Jehan El-Bayoumi, M.D., RESD ’88,
dedicates herself to delivering
medical care for all

compassion. One thing she said gave
me great strength over the next couple
of months. “You will not be alone in
your decision-making,” she said. That
meant a lot to me then, and it means a
lot to me now.
—June Jeffries

Support the School
of Medicine &
Health Sciences
By advancing our four-part mission — to
teach, heal, discover, and serve — the School
of Medicine and Health Sciences (SMHS)
seeks to change lives and better mankind.
SMHS offers a challenging and formative
educational experience designed to train
leaders in a swiftly changing health care
landscape.

THE CAMPAIGN FOR GW
SCHOOL OF MEDICINE &
HEALTH SCIENCES

SMHS is part of the George Washington
University‘s $1 billion philanthropic
campaign to support students, enhance
academics, and break new ground through
capital projects and research.
Your gift enables SMHS to have an impact in
the community, the country, and the world.

Join us in making history.
go.gwu.edu/makehistorysmhs

MAKING THE ROUNDS
The Fabric of Health Professionals’ Lives

For budding health care professionals, the simplicity of the
white coat belies its symbolism: not only does it mark the
start of a career, but it also represents the responsibility that
accompanies care. “Superman has his cape, Spiderman’s
got his tights, and I’ve got my white coat,” explained speaker
Michael Kahn, a second-year medical student at the GW
School of Medicine and Health Sciences (SMHS), at the M.D.
White Coat and Honor Code Ceremony on Aug. 8. “To those
we serve, it’s a symbol of healing, knowledge, and trust. And
for those reasons, it carries with it immense power.”
Kahn’s words tugged at a narrative thread that wove
through the speeches at the White Coat and Honor Code
Ceremony for the nearly 200 members of the Class of 2019.
Major General Nadja West, M.D. ’88, joint staff surgeon and
ceremony keynote speaker, explained that “I wear the cloth
of our nation in my uniform, but the threads of my white coat
are embedded in the fibers of this uniform here.”
For the physician assistant students, who formally
donned their coats at the Convocation and Short White Coat
Ceremony in late June, the addition to their wardrobe signified a willingness to carry their patients’ burdens. “The most
important thing it symbolizes to your patient is that you’ll
listen to them, and you will join them in carrying whatever it
is they brought in to lay before you,” said Susan LeLacheur,
Dr.P.H. ’08, M.P.H. ’89, B.S. ’80, associate professor of physician assistant studies at SMHS. Keynote speaker Robert
McNellis, PA ’91, M.P.H. ’91, who assured students that the
white coat is the first in a lineup of milestones, encouraged the Class of 2017 to “embrace this experience; it’s a
wonderful opportunity for you.”

Rounding out the formal donning of the white coat, the
new class of physical therapy (PT) students received their
coats at the PT Convocation Ceremony in late October.
“The White Coat Ceremony is a symbolic milestone, and it’s
especially important right now for our first-year students,
who have just embarked on their professional journey,” said
Joyce Maring, DPT, Ph.D., program director for the Doctor
of Physical Therapy Program, chair and associate professor
in the Department of Physical Therapy and Health Care
Sciences. “It promises to be a rewarding journey, but it’s one
of enormous responsibility, so thankfully we don’t make that
journey alone.” With those words, the second- and third-year
PT students, as is tradition, helped the first-year students put
on their coats for the first time.

GWMEDICINEHEALTH.COM
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MAKING THE ROUNDS

Inspiration at Graduation
Inspirational messages from student
speakers, keynote speakers, and
GW School of Medicine and Health
Sciences (SMHS) faculty blended with
the sound of bagpipes at the M.D. and
Health Sciences graduation ceremonies on May 16 and 17.
The M.D. program Class of
2015 received advice from keynote
speaker Vice Admiral Vivek H. Murthy,
M.D., M.B.A., the 19th U.S. surgeon
general. “It’s an honor to be here at

GW’s Rodham Institute
Hosts Third Annual Summit
Health equity is a pervasive theme in
discussions between health care workers
and advocates across the country
and around the globe, but it is also a
matter of critical importance here in
Washington, D.C.; despite its position
as the nation’s capital, the city is home
to some of the country’s most mediccally underserved neighborhoods. The
on-going dialogue on health equity
continued during the third annual
Rodham Institute Summit, at THEARC in
southeast Washington, D.C. Oct. 2.
The Rodham Institute, housed at
GW’s School of Medicine and Health
Sciences (SMHS) and supported by
the GW Medical Faculty Associates,
was founded in 2013 in honor of the
late Dorothy Rodham and seeks to
apply the transformative power of
education to achieve health equity in
Washington, D.C. This year’s summit,
themed “Celebrating Great Work in Our

4
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GW because of this institute’s longstanding commitment to creating
physician citizens,” said Murthy. “Your
leadership, your vision, your creativity,
and your courage will be essential in
creating an America that is as good at
preventing illness as it is at treating it.”
Jeffrey S. Akman, M.D. ’81, RESD
’85, vice president for health affairs at
GW, Walter A. Bloedorn Professor of
Administrative Medicine, and dean of
SMHS, took a moment to remember
Navdeep S. Kang, M.D. ’15, who died
in August 2014 during his fourth-year
of medical school. “He will forever be
connected to this university through
the Navdeep S. Kang Award for
Excellence and Service established by
his parents; the Navdeep S. Kang Class
of 2015 Scholarship, supported by his
classmates; and the Navdeep S. Kang
Student Lounge in Ross Hall,” Akman
said. Justin Michael Palanci, M.D. ’15,

was the first to receive the award.
The Health Sciences graduation,
meanwhile, recognized the program’s
culture of academic excellence among
its cadre of students. Traditionally, SMHS
recognizes the academic achievement
and service of its students at the graduation ceremony, but this year stood out
because so many students were worthy
of recognition. In addition to honoring
recent graduates who had served in the
military and those earning inductions
into honor society Alpha Eta, SMHS
faculty recognized three outstanding
students: Cassie Robertson, who
earned a bachelor’s degree in pharmacogenomics and was awarded the
Outstanding Undergraduate Award;
Angela Vince, M.A., who received the
Outstanding Graduate Student Award;
and Elizabeth Prevou, PA-C, M.P.H., who
also accepted the Outstanding Graduate
Student Award.

Community: Health
Equity Success Stories,”
included panels on
front-line health care
and mental health, a
poster presentation,
and a panel on childhood obesity featuring
Chelsea Clinton, vice
chair of the Clinton
Foundation.
“I’m just so grateful
that the work that the
Rodham Institute and
GW are doing now is in the same line
that everyone should be able to determine their own paths, and that so often
things like childhood obesity really are
questions of social justice and equity,”
Clinton said.
The day-long event also included a
speech by former Senator Chris Dodd,
a workshop by Deborah Johnson,
and the 2015 Academic Community
Collaborative Award ceremony, during
which Jehan “Gigi” El-Bayoumi, M.D.,

RESD ’88, founding director of the institute and professor of medicine at SMHS,
awarded three grants totaling $35,000
to collaborative projects.
“This summit was not only about
celebrating the great work that’s being
done every day by silent heroes in our
community that lifts people so that they
can be healthier and able to lead happier
lives,” said El-Bayoumi. “It’s also about
sharing and exchanging experiences and
maximizing the collective work being
done to improve our city’s health.”

There When the Earth Moves
When a 7.4-magnitude earthquake
struck Nepal in late April, the Fairfax
County Urban Search and Rescue team
had just begun its annual three-day
exercise; after news of the devastation
spread, the team grabbed its equipment — luckily already prepared — and
jumped on an airplane.
As soon as the 57 volunteers,
including Bruno Petinaux, M.D., RESD
’02, associate professor of emergency medicine at the GW School
of Medicine and Health Sciences
(SMHS), and medical director Anthony
Macintyre, M.D., RESD ’96, professor of
emergency medicine at SMHS, and six
dogs landed, they got to work. While
structural engineers and specially
trained squads assessed the feasibility of rescue attempts, Petinaux and
Macintyre worked to sustain the lives of
those entombed.
“Some of these extrications can
take many hours, so, initiating the care
as soon as we can, is vital,” Macintyre
said.

The physicians, who must grapple
with access to their patients and a
ticking clock of survivability, evaluate
the injuries, which span the spectrum
between minor cuts and bruises and
major life-threatening trauma, such as
“crush syndrome.”
“Any time you take a large amount
of muscle mass and put pressure on
it for a sustained period, you begin to
kill that muscle mass,” Macintyre said.
“Then when you remove that pressure,
it can release toxins into the bloodstream that can cause you to get sick
very quickly.”
The rescue team, known as USA-1
on its international deployment,
achieved several successful rescues,
including that of 15-year-old Pembe
Tamang, who had been trapped under
a hotel parking garage. His emergence from the rubble was a triumph
for the teams involved. Petinaux and
Macintyre, however, sum up their
efforts simply. “[We’re] just one piece
of the puzzle,” Petinaux said.

GW SMHS Opens
Dermatology Residency
The GW School of Medicine and Health
Sciences (SMHS) has reopened its
residency doors for a new specialty:
dermatology. The program, which
began in July 2015, enrolls two residents each year who will master the
medical, surgical, and histopathological components of dermatology
while working with a multicultural and
socially diverse patient population in
Washington, D.C.
“GW and Washington, D.C. create
an ideal environment for residents to
develop the skills necessary to thrive
in any medical setting,” said Adam
Friedman, M.D., associate professor
of dermatology, dermatology residency program director, and director
of translational research in the
Department of Dermatology at SMHS.
“It’s my goal to help develop future
dermatologists through our rigorous
and supportive teaching environment
and innovative research initiatives,
and by example of excellence in
patient care.”
The curriculum includes comprehensive instruction and exposure in
medical dermatology, dermatologic
surgery, pediatric dermatology,
dermatopathology, consultative
inpatient dermatology, and several
subspecialty areas. Residents will
rotate through ambulatory clinics and
inpatient consultation services at the
GW Medical Faculty Associates and
the GW Hospital; the Washington, D.C.
VA Medical Center; and Children’s
National Health System. They also
will attend clinical conferences and
lectures led by faculty from both SMHS
and the surrounding metropolitan
medical community.
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A Path to the Future
The immersion of the GW School of
Medicine and Health Sciences (SMHS)
DC Health and Academic Preparation
Program’s (DC HAPP) Cohort 3 into
medicine began with a white coat
ceremony.

“It’s really just symbolic of the fact
that we take this opportunity to participate in your future. Your future success
and your careers very seriously,” said
Yolanda Haywood, M.D., RESD ’87,
B.S. ’81, associate dean for diversity,
inclusion, and student affairs; associate

professor of emergency medicine; and
overseer of DC HAPP. With a hug and
smile, she held up white coats as the 13
participants — all students from local
high schools and charter schools — slid
them on. “I hope you remember this
when you go to med school,” Haywood
added to participant Kevin Peralta.
“This program is perfect for me,”
Peralta said later. “No one in my family
— or anyone I know — is a doctor, so I
wanted to surround myself with people
who had the same goals and the same
ambition that I did.”
Peralta, with Cohort 3, learned
the ins and outs of a medical education in the month-long program.
Highlights included trips to the VA
Medical Center, the Gross Lab, the
birthing simulation lab, and students
were certified in CPR.
“Now that I’ve done this program,
I feel like it really turned on my passion
for medicine,” Peralta said after learning
how to suture in the WISE lab.

From Here to Monrovia: Tackling Ebola
For the physicians and physician assistants tending to Ebola
patients in Monrovia, Liberia, the line between survival
and death was opaque. “You never knew who was going to
survive,” said Brian Burt, PA-C ’03, B.A. ’96. “One day you’d
go see the patient, and they’d be in complete renal failure
with massive, life-threatening electrolyte disturbances, just
unable to talk, incontinent. Then the next time you’d come
back, they’d be nearly turned around. On the other hand,
you’d have somebody that was doing great and motoring
along, and the next day you’d come, they’d be dead.”
Burt, along with GW School of Medicine and Health
Sciences (SMHS) classmate Mark McKinnon, PA-C ’03,
deployed with the United States Public Health Service
Commissioned Corps to Monrovia to provide care to health
care workers infected by Ebola. Conditions were hot and
humid, and comforts were minimal. Given that needlestick
injuries carried a nearly 100 percent infection rate, their
Ebola treatment unit had a constant rotation of patients,
some from the same family.
Families also made up a number of patients for
Colleen Kovach, M.D., clinical instructor of emergency
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medicine at SMHS, who treated Ebola-infected Liberians.
On one of her first days in the country, she encountered
the body of a 7-year-old boy; he’d died hours before, and
Kovach had to inform his mother, also stricken with Ebola
and in a bed next to her son.
Despite the heartache, the trio of volunteers left with
memories of survivors, survivor ceremonies — colorful
ribbons tied to a tree, yellow handprints slapped on a blue
wall — and a desire to keep helping.
“I love the humanitarian response,” said Kovach, who
also served along the Turkey–Syria border in summer
2015. “I’m hoping to make a career out of it.”

New Ph.D. Program Prepares Experts to
Translate Science into Solutions
The GW School of Medicine and
Health Sciences (SMHS) has launched
a Ph.D. program in translational health
sciences. The program is designed to
prepare health care professionals and
leaders to create, translate, disseminate, and integrate knowledge across
disciplines. As a result, graduates
will be prepared to improve health
care practice and research, positively influence health policies, and
develop the next generation of health
professionals.
“We are pleased that we are able
to provide this specialized education to
address a major need in our health and
education systems,” said Joe Bocchino,
Ed.D., M.B.A., senior associate dean for
health sciences at SMHS. “Right now,
new discoveries are made; however,
they take too long to reach the public
and affect complex health conditions
that require a sustained and widespread response.
“Our goal,” Bocchino continued,
“is to create a field of experts and

Changing Career Course
Hopeful medical students without a
background in general and organic
chemistry, biology, physics, and
biochemistry have an opportunity to
buttress their educational foundations
before applying to medical school.
In summer 2015, GW’s School of
Medicine and Health Sciences (SMHS)
began admitting students for its new
Post-Baccalaureate Pre-Medicine
Program at GW’s Virginia Science
& Technology Campus (VSTC). The
program helps students prepare
for the medical admissions process,
including the interview and the newly
designed MCAT exam.

educators who understand how
to expedite the process and integrate science from the bench to the
bedside.”
The program, which is directed
toward licensed health professionals
and clinicians, health care administrators, public health professionals, and
educators, focuses on three areas:
expanding translational research,
improving health care practice, and
advancing the development of educators who support the medical and
health professions. The Ph.D. requires
52 credits beyond a master’s degree,
as well as completion of two comprehensive examinations, a proposal
defense, and a defended dissertation.
Students will participate in courses
online and spend two weekends per
semester at the Virginia Science &
Technology Campus.
LINK: smhs.gwu.edu/translationalhealth-sciences/

“This program is designed to
provide candidates with the foundational course work, standardized test
preparation, and access to real-world
experience necessary for a successful
matriculation into medical school,”
said Lisa S. Schwartz, Ed.D., program
director of the Post-Baccalaureate
Pre-Medicine Program. “This is the next
step for someone who wants to change
careers and pursue his or her goal of
becoming a physician.”
The program, part of a continuing
expansion of the health sciences
programs at SMHS, features faculty
mentors and 7,000 square feet of laboratory and support space at VSTC.

When Pope Francis visited
Washington, D.C. Sept. 22–24, the
nation’s capital paused. Even Congress
broke from its usual schedule to listen
as the pontiff addressed a rare joint
session. Being in Washington, D.C.
means the GW School of Medicine
and Health Sciences (SMHS) community gets a front row seat on the
action. Oftentimes, it also means
SMHS is called upon to support that
action. For the papal visit, a team
of SMHS students, residents, and
physicians from the Department
of Emergency Medicine provided
medical support during the Pope’s
mass at the Catholic University and on
the National Mall when he addressed
Congress.
The SMHS team covered the
events as part of the GW Medical
Faculty Associates Medical Reserve
Corp, a federally recognized medical
response team, under the authority
of the U.S. Department of Health
and Human Services and the D.C.
Department of Health. The team
may be called upon to assist at mass
gatherings, national security events,
public health crises, and regional
disasters.
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Illuminating
Pediatric
Dysphagia
Genetic mouse model takes
center stage as researchers
investigate feeding and
swallowing disorder

BY CAROLINE TRENT-GURBUZ

“C

an you imagine,” says Anthony-Samuel
LaMantia, Ph.D., director of the GW
Institute for Neuroscience and professor of
pharmacology and physiology at the GW
School of Medicine and Health Sciences (SMHS), “you’re an
infant, and one of the key behaviors you have to learn is to
ingest food. Someone comes at you with food, and it hurts! It
makes you hurt.” That pain, a product of pediatric dysphagia,
is at the heart of what LaMantia and his team — a veritable
A-list troupe of basic science investigators — are working to
solve. With a five-year, three-pronged plan and a $6.2 million
program project grant (PPG) from the Eunice Kennedy Shriver
National Institute of Child Health and Human Development,
PPG director LaMantia is determined to tackle the problem
where it begins: in the brain. That’s where our story starts.

Act One: The Basics
Pediatric dysphagia, a swallowing and feeding disorder,
presents as a mostly mechanical problem; infants and children
are unable to chew and swallow and may aspirate or choke
on what they try to consume. Complications include ear and
sinus infections and dribbles of liquid that settle in the lungs.
There’s also some suggestion that the scent and texture of
food may be unpleasant or aversive, a result of disrupted
sensory and olfactory modalities.
Today, dysphagia is treated symptomatically. There is no
cure, and researchers understand little about a disorder that
ranges from mild to severe. What researchers do know is that
it can appear in as many as one in four children, and that up
to 80 percent of those with neurodevelopmental disorders,
such as autism, have dysphagia. “This is a real-life disease,”
LaMantia says.
Dysphagia is also a tricky disease. As LaMantia points out,
delving deeper into the “whys” and “hows” of a disorder that
appears in babies has limitations; researchers and physicians
would prefer using minimally invasive techniques with infants.
The ideal solution, therefore, is an animal model.

Act Two: The Mouse Model
LaMantia has dedicated the past 15 years to DiGeorge
Syndrome, or 22q11.2 Deletion Syndrome, which occurs when a
small part of chromosome 22’s long arm is missing. The effects
are far-reaching; patients suffer from a medley of complications: heart defects, cleft palates, autism or intellectual
disabilities, and pediatric dysphagia. LaMantia’s research on
DiGeorge Syndrome — and the genetic mouse model he and
his team use — unlocked the link between the deletion and the
resulting dysphagia.

GWMEDICINEHEALTH.COM
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“It is remarkable how good a model this is,” LaMantia
says. “The insight that we were initially able to get supported
our basic hypothesis.”
That hypothesis, based on past research for eye
movement disorders, was that dysphagia emerges when fundamental mechanisms in early brain development are disrupted,
causing defects in the neurons that become part of the cranial
nerve system. As a result, craniofacial formation and associated swallowing and feeding apparatuses are negatively
affected. The discovery, outlined in a 2013 study published
in Disease Models & Mechanisms, revealed that dysphagia
develops embryonically, not after a baby is born. With that
in mind, the researchers at GW and clinical partner institution Children’s National Health System (Children’s National)
decided to use the mouse model as a platform for further
understanding dysphagia.

Act Three: The Team
To best tackle the causes of dysphagia, LaMantia and PPG
associate director Sally Moody, Ph.D., professor of anatomy
and regenerative biology at SMHS, assembled a cast of experts
in mouse genetics, bioinformatics, maternal nutrition, and
neuronal functioning.
“The project was put together to try to attack the problem,
or at least analyze the problem, from a multidisciplinary
perspective,” Moody explains. “We all have very different backgrounds and training, and we put together three big projects
that are combining all of those aspects. It’s the combination of
expertise that we think will allow us to make progress.”

Act Four: The Project
The investigation is divided into three parts: the origin of
dysphagia, the pathology, and a possible path to prevention,
all of which researchers will pursue simultaneously while
informing one another of their progress.
Part one, headed by David Mendelowitz, Ph.D., vice chair
and professor of pharmacology and physiology at SMHS, with
Norman Lee, Ph.D., professor of pharmacology and physiology at
SMHS; Thomas Maynard, Ph.D., associate research professor of
pharmacology and physiology at SMHS; and Anastas Popratiloff,
M.D., Ph.D., adjunct professor of anatomy and regenerative biology at SMHS. The team is focusing on dysphagia in
newborns. More specifically, the researchers will assess any
abnormalities in the neuroanatomical connections that control
the muscles an animal uses to feed and swallow. “Are the neurons
that have to control muscular contraction the right size?”
LaMantia asks. “Do they have the right synaptic inputs?”
One experimental strategy that has shed light — literally
— on certain aspects of dysphagia is a technique similar to a
barium swallow. Using a contrast agent, in this case a fluorescent dye, mixed with formula, Maynard has been able to track

10
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the path of the liquid as it passes through both the normal and
the genetically altered mice. In normal mice, some drops of dye
collect in the crevices of the tongue, but most passes through
the mouth en route to the stomach.
“In contrast, in a couple of mutants that we’ve tried, we see
a whole bunch left in the mouth,” Maynard says. “If you look in
the sinuses, there is food that they tried to swallow but that was
kicked back up into the nasal regions.”
In another indication of the mutant animals’ difficulty
in eating and swallowing, the researchers have found that the
mutants also grow at a slower pace than their non-mutant siblings.
In part two, LaMantia, Moody, and Lee are zeroing in
on the development of the embryonic hindbrain. In early
developmental stages, a population of cells migrates from the
hindbrain into the periphery to make craniofacial structures.
For infants with dysphagia, somewhere along the way the
mechanisms controlling how these cells develop into peripheral neurons and the facial skeleton go awry. “The brain has
to have a code, and the periphery has to have a code, and
they have to match,” LaMantia says. When they don’t match,
messaging between the two becomes garbled. A second
important goal of the part-two team is to identify the genes
that are altered in the hindbrain that lead to the motor and
sensory mismatches.
The third part of the project is what LaMantia and Moody
term the most adventurous. Retinoic acid, a derivative of
Vitamin A, is one of the signaling factors strongly affected by
the 22q11.2 deletion. Hypothesizing that maternal nutrition —
in particular retinoic acid as it plays a role in the development
of the hindbrain — could influence the severity of dysphagia,
Irene Zohn, Ph.D., associate professor of pediatrics at SMHS
and a researcher at Children’s National, along with Maynard, is
experimenting with maternal diets.
“We’ve shown that with this particular mouse model,
Vitamin A can modify phenotypes,” Zohn says. “So the goal of
my project is to determine how changing the Vitamin A — having
either borderline deficiency or too much Vitamin A — might alter
the severity of feeding phenotypes.”

Act Five: The Goals
Although the team is still a few years away from the project’s
conclusion, the researchers’ goals could have long-lasting
consequences for dysphagia sufferers, some of whom cope with
the disease well into adulthood.
“We’re hoping that there might be ways of regulating
[dysphagia] either prenatally via diet or postnatally through
pharmacological therapies to help the kids overcome this
behavioral deficit that really impacts their lives,” Moody
says. “Also, we think if we can figure out the problem with
this syndrome, the information may be applicable to other
syndromes where children also show dysphagia.”

Caring for a President

T

his year marked the 150th anniversary of one of
the most monumental events in Washington, D.C.
history, and indeed U.S. history: the assassination
of Abraham Lincoln. The tragic event cemented
the George Washington University School of Medicine and
Health Sciences (SMHS), or National Medical College of
Columbian University, as it was known at the time, in its unofficial role as the health care provider to the world’s leaders.
The following is a timeline of events based on National
Archive records and accounts from Elmer Louis Kayser’s
1973 history of the George Washington University’s
academic medical programs, titled “A Medical Center: The
Institutional Development of Medical Education in George
Washington University.”
On April 14, 1865, just five days removed from the unconditional surrender of Confederate forces and six weeks after
his second inauguration, President Abraham Lincoln and
first lady Mary Todd Lincoln join others in a private box at
Ford’s Theatre to watch a performance of the comedy “Our
American Cousin.” Also in attendance is Maryland native and
Confederate-sympathizer John Wilkes Booth.
At 10:13 p.m., Booth enters the private box and pulls the
trigger on a .44 caliber, single-shot derringer pistol aimed at
the back of the president’s head. During his escape, Booth
produces a knife and stabs U.S. Army officer Henry Rathbone,
who was attending the play with the Lincolns and his fiancée,
Clara Harris, the daughter of New York Senator Ira Harris.

BY THOMAS KOHOUT
First on the scene to aid the president is 23-year-old
Charles Leale, M.D., who has only weeks before completed his
medical training. Through physical examination, Leale determines a bullet has penetrated Lincoln’s skull just behind his left
ear. The president is left paralyzed and barely breathing.
Albert Freeman Africanus King, M.D. 1861, a graduate of
the National Medical College of Columbian College, is seated
below the president’s box in the orchestra section. King, just 24
years old, will go on to become professor and chair of obstetrics
and serve as dean of the National Medical College from 1879 to
1894. He climbs to the box above, joining Leale in an effort to
revive the president. After a medical examination, the young
physicians help carry the president across 10th Street to the
home of William Peterson.
Lincoln’s personal physician, Robert King Stone, M.D.,
a faculty member at National Medical College and former
dean of the medical faculty (1853), is summoned to Lincoln’s
deathbed. Upon arrival, Stone assumes the role of chief
attending physician for the mortally wounded president.
John Frederick May, M.D., professor of surgery and
anatomy and another former dean of National Medical College,
is called to Lincoln’s bedside for consultation. Twelve days
later, May will be called upon to help identify the body of John
Wilkes Booth.
Nine hours after the shooting, at 7:22 a.m. on April 15,
Lincoln dies. At his bedside, Secretary of War Edwin Stanton
remarks, “Now he belongs to the ages.”

BY ERIC BUTTERMAN

“I

just want to say one word to you. Just one word.
Plastics. There is a great future in plastics.”
So goes an early scene in the 1967 Mike Nichols
classic The Graduate. The pitch from a seasoned
executive attempting to recruit the young college graduate
played by Dustin Hoffman is an ideal symbol for the rapidly
changing 1960s. It also alludes to the exponential growth in
the use of, and reliance on, the synthetic polymer. Seemingly
overnight, the use of plastics exploded in the mid-20th century,
and soon a host of polymers could be found in everything from
textiles to food packaging and even medical supplies. But plastics’ rapid acceptance and widespread use posed a potentially
serious problem.
At least that’s what Ronald Brown, a toxicologist for
the FDA, considered a possibility. In 2008, he asked Narine
Sarvazyan, Ph.D., professor of pharmacology and physiology
at GW’s School of Medicine and Health Sciences (SMHS) to
collaborate on a toxicity project. Few at the time could imagine
that it would lead to a scientific odyssey that continues to this
day. Brown wanted to confirm whether there were potential
cardiovascular problems associated with the chemical makeup
of certain types of plastics regularly used in medical devices,
specifically a chemical called Di-2-ethylhexyl phthalate
(DEHP). Sarvazyan and her team then decided that the best
approach to start would be to test whether DEHP had any
harmful effects on isolated heart cells.
Like the Hoffman character, Nikki Gillum Posnack,
Ph.D. ’09, then a fourth-year graduate student in Sarvazyan’s
lab, was dealing with the pressures of the rapidly approaching
end to her doctoral training. Tasked with analyzing the cardiac
effects of plastics, Posnack was skeptical, thinking it might not
be the best use of her remaining time as a student. “We were
interested in seeing if some of these plastic components could
have adverse heart effects,” recalls Posnack, now an assistant
research professor of pharmacology and physiology at SMHS.
“There was very little available research on this chemical. So,
we treated heart cells with a dose of a DEHP that mimicked a
young patient’s exposure in the clinical setting. But, we did not
observe any immediate effects of DEHP in our experiment.”

Posnack could have stopped with the initial tests and
perhaps considered the matter closed. But a decision to put the
treated heart cells into an incubator changed everything.
The research team was startled to see that over time,
arrhythmias began forming in the cardiac cell preparations.
“Cells in your heart should be well coupled to allow for fast
and uniform electrical conduction,” explains Posnack. “But
these heart cells were communicating and beating on their
own, independently of one another.”
After the discovery, not surprisingly, further testing was
done, and by this time enthusiasm had replaced Posnack’s
skepticism.
Posnack is now a first author on six peer-reviewed articles
detailing adverse effects of plasticizers on heart physiology.
She expanded her initial DEHP studies to also examine the
influence of Bisphenol A (BPA), another plastic component, on
heart cells and the heart as a whole. “Starting at low doses, we
saw slowing of electrical conduction,” she says. “We detected
both slowing of conduction velocity across the heart and
delayed conduction between the atria and the ventricles.”
Posnack explains that BPA is usually found in polycarbonates — shatterproof plastics, food and beverage containers,
and as a liner in aluminum cans. Global production of BPA,
according to Merchant Research and Consulting, reached 4.6
million tons in 2013. In other words, people around the world
come in contact with BPA on a daily basis.
“There is not a whole lot of information on whether these
plastic chemicals are affecting the cardiovascular system,”
she says. “We know we’re being exposed to these chemicals
on a routine basis … it’s clearly a public health concern. Public
health studies have recently shown associations between exposure to plastic chemicals and adverse cardiac effects, but we do
not have a whole lot of basic science research to show if those
effects are directly linked or not.”

Leading the Way

What Posnack once considered a dull assignment now accounts
for a significant portion of her professional hours. The reluctant graduate student is now an enthusiastic research professor
playing a lead role in plastic-related health care studies. And,
as the mother of two children under 6, she has found that
her efforts to uncover plastic’s effects, particularly related to
childhood development, have grown into an obsession. “Look
around,” she says. “Plastics and families go hand in hand. As I
child, I remember drinking out of small juice glasses, but now
it’s hard to find something that is not made of plastic. I’ll admit
that we’ve switched to stainless steel bottles for our kids. … If
my husband sees someone microwaving something in plastic,
he tells them ‘glass is the way to go.’ But, even with those
precautions, children don’t have a lot of wood or natural toys
anymore. Everything is plastic. You can’t avoid it.”

Exposure levels for people who are undergoing bypass
surgery or receiving blood transfusions are much higher than
typical, says Posnack, explaining that the procedures “involve a
good amount of plastic tubing or storage bags.”
Now a full year into a K99 grant, she’s also started a collaborative study with Paul Marvar, Ph.D., assistant professor of
pharmacology and physiology at SMHS, to explore the in vivo
effects. “We’ve started to record electrocardiogram and blood
pressure measurements at low dose exposures using radiotelemetry,” she explains. Human studies “have linked higher
DEHP and/or BPA exposures with having high blood pressure,
decreased heart-rate variability, and an increased risk of heart
attack. With this telemetry system, we can look at the direct
link between exposure and alterations in heart rate and blood
pressure over time.”
Sarvazyan, Posnack’s mentor and co-author, considers
her protegée’s work to be vitally important and assesses her as
just the person to see it through. “Imagine your loved one goes
to the hospital, and they have an underlying cardiovascular
problem,” she says. “Then these chemicals migrate out of plastic
medical devices into their blood, exaggerating what is already a
dangerous situation. Dr. Posnack has already shown that high
concentrations of BPA and DEHP can negatively affect the
hearts of small animals, and she is fully set to understand the
effects of clinically relevant concentrations of these compounds.
“Moreover,” adds Sarvazyan, “she can now test the effects
of these compounds on a person’s own cardiac myocytes,
which can be derived from a small blood sample using induced
pluripotent stem cells technology. ”
But while Posnack pushes on, she keeps in mind the value
that plastics have grown to represent in society. It’s why, she
says, we have to understand how best to use them — as opposed
to eliminating them.
“Plastics are very important, and they save people’s lives
every day in hospital settings,” she says. “We’re not trying
to rid the world of plastic, but we are trying to get a better
understanding of the risk and [figure out] if, in some case, there
are alternatives that may be better. People need to remember
these chemicals are also found in things other than plastic.
BPA can also be found in aluminum cans, and it can be used in
thermally printed cash register receipt paper. Yes, DEHP is a
plasticizer, but phthalate chemicals can also be used in many
personal care products with fragrances, such as shampoo.
Many people don’t understand how far this reaches.”
Despite the possible outcomes, Posnack knows that on her
way to the truth, part of her job is not to scare people unnecessarily. “For those in science, many want to know what level of
concern there should be, but it’s hard to walk an intermediate
line and not be an alarmist,” she says. “But that’s a challenge
you have to take on. … I’m hoping the results I find are helpful
— no matter what they ultimately tell us.”

GWMEDICINEHEALTH.COM

13

A

lthough he speaks in measured tones, Eduardo M.
Sotomayor, M.D., director of the new GW Cancer
Center (GWCC), exudes optimism and determination as he describes his vision for the institution:
“Driving research innovation, personalized cancer care, and
cancer policy from the nation’s capital.” He scrolls through
a PowerPoint presentation, recently given to the GW Board
of Trustees, and points out his regular caveat, “Not related to
SCOTUS Judge Sonia Sotomayor.” He laughs before returning
to his institutional mission, an inclusive and expansive
approach to cancer.
GWCC will act as an umbrella, he explains,
encompassing various facets of cancer care, from basic, translational, and clinical research to policy (“It’s my pet project,”
he confides) and advancements in treatment. He plans to
recruit talent from both inside and outside GW, creating a
powerful task force for cancer. His more immediate goals
include earning a prestigious National Cancer Institute
(NCI) designation. The demands are rigorous, but not
unfamiliar for a man who frequently transforms the phrase “I
think I want to do this” into reality.

From the Beginning
Sotomayor, who readily describes himself as a physician-scientist,
started his journey in medicine at age 7, during a trip to the
hospital to be treated for an infection; he was fascinated by
the health care providers’ compassion. Visits from an uncle,
a medical student, cemented his desire to pursue medicine.
“At that point, with these two experiences together, I said, ‘I
think that I want to be a doctor,’” Sotomayor recalls, a smile
spreading across his face at the memory. “My mom said, ‘Are
you sure?’ and I said, ‘I want to be a doctor.’”
The ensuing years saw Sotomayor power through secondary
and post-secondary school in his native Peru, culminating in
graduation from Federico Villarreal Medical School in Lima.
He worked for one year in the Peruvian countryside — part of
a payback agreement with the government for a tuition-free
education — before relocating to Fort Lauderdale, Florida. His
initial area of interest was rheumatology.
“I was able to meet Dr. Diana Lopez,” Sotomayor says.
“She is an immunologist, but she was not working on autoimmune disorders. She was not working in rheumatology. She was
working in cancer. I had a meeting with her and said, ‘OK, I
think this is what I want to do.’”
For Diana Lopez, Ph.D., professor of microbiology and
immunology and director of the undergraduate program
at the University of Miami Miller School of Medicine,
Sotomayor was a memorable colleague, making his subsequent rise through medicine no surprise to her. “He
impressed me so much,” she says. “He really is amazing.
Hardworking, intelligent, dedicated.”
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Sotomayor worked with Lopez for three years before he
felt the need to return to clinical medicine. “He wanted to
do his training as a medical doctor, because that’s what he
was,” Lopez explains. “He did it here at Jackson Memorial
[Hospital], and then he wanted to go and do more research.”
Sotomayor landed at Johns Hopkins University in 1995,
where he joined a group of oncology researchers working
under Hyam Levitsky, M.D. “They were passionate, and
they truly believed that one day cancer immunology would
be an area that would provide effective cancer treatments,”
Sotomayor says. “So I said, ‘OK, I think I want to be part of
this group.’ ” The researchers were tackling the role of healing
T-cells and their ability to destroy cancer cells. Sotomayor
narrowed his focus to lymphoma, specifically analyzing the
interaction between T-lymphocytes and cancer cells, and the
growth of cancerous tumors. Despite skepticism at the time,
he was confident in cancer immunotherapy as a revolutionary
approach to treatment.

Sotomayor is tapping to head crucial research.
“I believe in internal recruitment,” Sotomayor says. “The
[researchers, scientists, and engineers] are going to be focusing
on areas that a few years from now, we can claim that we are the
leaders in.”

Finding a Niche

Sotomayor:
Physician,
Scientist,
Researcher,
Visionary
BY CAROLINE TRENT-GURBUZ

“In 2015, everybody loves cancer immunology,” Sotomayor
says. “Everybody’s a believer because in the last five years, we’ve
had many successes. Everybody wants to be a cancer immunologist now.” He adds, jokingly: “I’m kind of a pioneer.”

Pioneering Cancer Research and Treatments
As part of his proposed scientific program for GWCC,
Sotomayor intends to explore cancer immunology and
immunotherapy; his initial plans include expanding ongoing
T-cell clinical trials at Children’s National Health System and
further developing a cell therapy lab and stem cell transplant
program at GW Hospital. He also wants to incorporate the
promising fields of cancer epigenetics and microbial oncology,
the latter of which pulls in Doug Nixon, Ph.D., Walter G.
Ross Professor of Basic Science Research, chair and professor
in the Department of Microbiology, Immunology, and
Tropical Medicine at the GW School of Medicine and Health
Sciences. Nixon is one of the aforementioned internal talents

Sotomayor’s resolve to earn the NCI designation is, like his
decision to emphasize cancer immunology and research, reflective of his past experience. Four years after joining the team
at Johns Hopkins, Sotomayor felt the balmy winds of Florida
calling him back.
“I met Eduardo when he was finishing his fellowship at
Hopkins and recruited him to Moffitt,” explains William S.
Dalton, M.D., Ph.D., former president, chief executive officer,
and center director of the H. Lee Moffitt Cancer Center and
Research Institute at the University of South Florida in Tampa.
“It was one of the best hires I’ve ever done.”
At Moffitt, Sotomayor served as the scientific director
of the center’s DeBartolo Family Personalized Medicine
Institute, and at the national level he joined several committees, including the NCI parent committee A, where he
helped review NCI-designated centers. The criteria for
earning the designation include having established, collaborative research programs and an institutional commitment
to, and capability for, cancer care. GW is poised to be the
next center on the list.
“We’re going to find our own niche,” Sotomayor says. “I
think by doing that, we’re going to have a very good chance
down the road to get an NCI designation.”

The Future: Personalized Medicine
The final component of Sotomayor’s approach is as revolutionary and forward thinking as cancer immunotherapy:
personalized medicine.
“Personalized medicine in my view has two essential
components,” Sotomayor explains, pointing to phenotype and
genomic data. “You need both.” The key for the components
is creating tissue-related and demographics-related databases,
where doctors and researchers can determine the makeup of
past and current cancer patients; ideally, the information can
be used to guide more precise, individualized treatment. “We
want to provide state-of-the-art clinical care, we want to do
novel clinical trials, and personalized cancer care will be the
engine speeding up these efforts,” Sotomayor says. “That’s
where the field is moving.”
The people in his life, those who’ve observed his ascent,
believe his success — like the success of GWCC — is guaranteed.
“[GW is] very lucky to have him as the new director,”
Lopez says.
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MAKING STRIDES
in Childhood Intellectual Disabilities
and Autism

BY ERIC BUTTERMAN

W

hen Maria Chiara Manzini, Ph.D., was a first-year
student at the University of Pavia in Italy, she had
her choice of careers. Ultimately, she focused on
studying the brain and behavior, but she couldn’t
shake one thought. “I was always struck by how, in many
cases, psychiatric disorders are chemical imbalances, but they
completely change your personality,” says Manzini, assistant
professor of pharmacology and physiology at GW’s School of
Medicine and Health Sciences. “When you have high blood
pressure, it’s treated with a drug, and you’re reset to normal
levels. But with psychiatric problems, it overtakes so much of
your life. I realized how unfair and how misunderstood it was.”
That combination of compassion and curiosity has
helped guide Manzini on a nearly decade-long journey to help
improve the lives of children with intellectual challenges and
autism. An award presented by the Eunice Kennedy Shriver
National Institute of Child Health and Human Development,
which started as a career-development grant during Manzini’s
postdoctoral career, grew on her promise as an investigator to
become $740,000 to be applied to her independent research
into severe intellectual disability and autism caused by loss of
function of the CC2D1A gene.
Manzini’s project, titled “Intracellular signaling in the
development of human cognitive function,” explores the function of the gene and of the mutations that cause disease by both
using cell-based systems — analyses of neurons generated from
animal models — and studying the behavior in mouse models to
better understand the pathogenesis of the disease.
Autism does not fit a simple definition, according to
Manzini, who earned her doctorate in neurobiology and
behavior from Columbia University. “That’s why it’s called
autism spectrum disorder. We now know that it can have
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multiple different causes,” she says. “We also know it’s a developmental disorder and most likely starts in the fetus, but it is
often diagnosed when a child is 2 or 3.”
She categorizes the intellectual disabilities at the center
of her research as severe. “An example would be someone who
grows up to be a 30-year-old who functions at about the level
of a 3-year-old and is able to say around three words,” she says.
“They never adapt and continue to have the capacity of a very
small child.
“For example, they probably don’t know what money is,
and they might have issues with expressing themselves,” she
explains. “With autism, it’s also issues in social interaction
and repetitive behaviors.” One thing they all have in common
is that they have no other physical or neurological conditions,
and their only difficulties are in brain functions controlling
cognition and behavior.

DETECTIVE WORK

Manzini still remembers the excitement of discovering the
CC2D1A gene mutation in 2006 at the Boston Children’s
Hospital lab that led to so much of her work. “We found it in
the DNA sequence, but we didn’t know anything about what
losing that gene did to the brain” she says. “You needed to
generate a model to look at the brain to see if it’s normal —
asking questions like: Does the animal model have a learning
deficit or a social deficit? We could find the source of the
problem in the genetics, but you can find the gene and still not
know what that gene does. It’s truly detective work.”
She knew early on that she wanted to get beyond identifying the genes, to figure out how the gene regulates multiple
signaling mechanisms inside the cells, as well as how it
responds to the outside. Only then can Manzini establish ways

can measure the strength of these electrical signals and see
whether the cell is able to increase its strength. But, in our case,
in our models, that doesn’t happen. … Where we’re at now, we
have cellular deficits and some other deficits, but what we want
to do is to get the molecular deficit. So, we go inside the cell and
figure out what is wrong and what is the cause.”

FAMILY MATTERS

to modulate the gene and have a positive effect on the disease.
“You see the neuron is not quite able to respond to stimuli from
the outside, and we’re trying to figure out from a molecular
point of view why there is the misinterpretation,” she explains.
“You also want to look into whether there are applicable drugs
available or hopefully create ones that will help restore normal
responses in the neurons.”
Presently, Manzini is focused on behavioral tests through
animal modeling, looking at learning capacity, social interaction, and whether the subject’s behaviors are repetitive.
Examples of tests include having a mouse subject in a cage with
a sibling and an unknown mouse and looking at how often the
subjects choose to interact with each other. “A lot of the time the
ones with social deficit won’t even care,” she explains. “If they
don’t have a social deficit, they’ll tend to go to the mouse they
don’t know because it’s someone new — they are checking out
if they’re friend or foe.” Or, to study anxiety, researchers might
put the mice in an open box and see how often they’re willing to
leave the sides and go into the open space in the center.
“We’re also looking at animals with self-injury and other
issues,” she says. “The final overarching goal is to understand
the molecular deficits caused by loss of this gene and see if we
can cure behavior in the animal model and extend that to other
autism research.” The problem, explains Manzini, is that literally hundreds of genes are affected. “We have to try to figure
out whether we can group patients based on genes with similar
functions, or do more when it comes to understanding how the
different genes work together.”
Manzini says her work is still in the early phase, and she is
working to understand why these mutations cause these effects
on brain function and development. “Specific electric signals
when you develop a memory become stronger,” she says. “You

Manzini’s passion grew partly out of meeting families affected
by autism, believing it was important to get beyond the microscope in this kind of work. “We have families in genetic labs
trying to get more information, and we have to try to help them
make sense of this genetic disorder,” she says. “It’s also very
helpful to see the positive [side] and the love of the parents for
these kids — it’s been really inspiring. I recommend that even
if you always work with DNA and just see the samples, you
want to understand what people are going through. By understanding the community and seeing what effect [a disease] has
on the quality of life, you can focus on those aspects of the
disease, and it can inform your work.”
One family visit led Manzini and her medical team as far as
a mountain peak at the tip of the Arabian Peninsula in Oman.
“You go through the desert, climb a dirt road, and they were
in a mud building on the top of a mountain,” she recalls. “They
were really excited to see us — I believe the two brothers and
their wives had seven children who were affected. You could
see how driven they were to find out what had happened to
their children and how much they wanted to help them.”
But the families go beyond offering inspiration — they’ve
provided vital clues. “When we first identified mutations in
CC2D1A, it was in a family who had severe cognitive deficits,”
she says. “Then another family with the same mutation had
intellectual disability, but also had autism. A third [who] had
a different mutation also had both intellectual disability and
autism.” Confusing, yes, but also challenging, says Manzini.
As Manzini trudges on, she is strongly encouraged by
improvements in the positivity of the medical community. “In
the past five to 10 years, we have gained a better understanding
of what causes these disorders,” she says. “And right now there
is a lot of focus on trying to develop therapies. It’s hard to
believe that just five years ago there weren’t really any clinical
trials! You want to know the difference? I was at a conference
recently, and it’s so great to see clinicians, scientists, and pharmaceutical companies talking about a variety of disorders and
assessing improvements in learning. Advocacy groups should
be very proud of the role they’ve taken.”
And it’s extra incentive for her to also see the way society
has changed its view. “Young children are receiving early diagnosis and extra help at home and in school,” she says. “Therapists
are playing a very important role. We can make their lives better
in many ways … and I think it will only improve.”
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When people reach the pinnacle of their profession,
we sometimes call them rock stars. They are
showered with adulation, and we say they’ve turned
their talents into performance art. For surgeons,
tasked with bridging science and art, intellect and
dexterity, the allusion is more fact than flourish.
BY STEVE GOLDSTEIN
BY STEVE GOLDSTEIN
PHOTOGRAPHS BY BARBARA
MCGOWAN AND MICHAEL LEONG,
BIOMEDICAL COMMUNICATIONS

Take J. Keith Melancon, M.D., professor of surgery and chief
of the Division of Transplant Surgery at GW’s School of
Medicine and Health Sciences (SMHS) and director of the new
GW Transplant Institute at George Washington University
Hospital (GW Hospital). Describing the charismatic and
dapper Louisiana native as a transplant surgeon is a little bit
like saying Mick Jagger has some stage presence. Which, in a
way, explains why Melancon got into the business of swapping
organs in the first place.
Melancon’s medical baptism first came from the hindquarters of a cow — more on this later — but he always envisioned
himself as a surgeon. As a boy in Lafayette, Melancon idolized Hawkeye Pierce, the wisecracking protagonist-M.D. of
the 1970s television show “M.A.S.H.” Through his mother, a
surgical nurse at Charity Hospital, he got a firsthand view of
the dominion doctors held in the hospital world.
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That impression — surgeons as saviors — became
permanently stitched on his psyche. Years later, Melancon,
a third-year medical student researching a project on transplantation, witnessed a daily miracle in the OR. “The surgeon
took the kidney out of the ice bucket, prepared the patient, and
connected the vessels and the kidney, which was white, pale,
and cadaveric,” he recalls. “Suddenly, it came to life.
“The surgeons were like rock stars,” Melancon exclaims. “I
wanted to be a rock star!”
Now a transplant surgeon, the 46-year-old father of four
boys has earned that status, with more “firsts” on his resume
than a van full of valedictorians. In 2009, Melancon, leading
the charge in making transplantation more widely available to the Washington, D.C. community, headed a team
that performed a 26-person paired kidney exchange — 13
recipients and 13 donors. A year later, he helped set a record

with a 32-person kidney swap. The key in both these massive
exchanges, says Melancon, is the altruistic donor — someone
willing to donate one of his or her two kidneys, which can set
off a “daisy chain,” in Melancon’s words, of matches between
donors and patients.
At GW Hospital in late June 2015, to the tune of classic rock
playing softly in the background, Melancon and Thomas Jarrett,
M.D., professor and chair of the Department of Urology at
SMHS, led such a daisy chain: a successful three-way paired
kidney exchange. The procedures were the first ever at GW
Hospital, and tricky ones at that. “The unique nature of the
exchange was the fact that all of these recipients had received
kidney transplants many years ago and were in need of new
transplants, but [the kidneys of] their loved ones did not match,”
he explains. “The patients were ‘sensitized,’ meaning it’s even
harder to find a match.”

The transplant program Melancon and colleagues are
building at GW, however, is dedicated to utilizing all means of
performing live donor transplants. “We were able to help these
patients find other transplant patients in the same predicament
of needing a better-matched donor than their loved one,” he says.
“We always aggressively push for local paired kidney exchange,
because it is the quickest, most convenient, most cost-effective,
and most reliable means of transplanting the most patients.”
“It’s not just one person,” adds Muralidharan Jagadeesan,
M.B.B.S., associate professor of medicine and chair of transplant
medicine at SMHS, and medical director of the renal transplant
program at GW Hospital, about the transplant team being
created at GW. “ It’s not just a surgeon, it’s not just me; it’s the
coordinator, the social worker, the pharmacist, the dietician,
it’s everybody on the GW transplant team who’s going to work
together to provide the service for you, so that you can participate on this very successful voyage of kidney transplant with us.”
With the increased incidence of precipitating illnesses
such as hypertension and diabetes, and the fact that donations
from deceased donors are, by necessity, limited, the GW transplant team has sought to bolster live donations through paired
exchanges using altruistic donors.
All this is made feasible by the fact that humans come
equipped with a spare kidney to share. The bean-shaped organ,
roughly five inches long and weighing a bit more than a bar
of soap, performs critical cleansing functions for the body,
filtering waste materials from blood to then pass them out as
urine. If the kidneys are not working properly, they can cause
havoc. When that happens, patients have to go on dialysis to
keep their bodies running, but sooner or later their kidneys
will need to be swapped out. The good news is, although we
are born with a pair, we can function just fine with only one
kidney. Despite that redundancy, demand still dwarfs supply.
Numbers underline the immediacy of the crisis. Some 26
million Americans suffer from chronic kidney disease, and fewer
than 400,000 of them have received kidney transplants. About
3,000 more are added to the waiting list annually, and roughly
4,500 of those on the transplant list die each year according to
the National Kidney Foundation. In the United States, more
than 100,000 people with renal failure are on the list for a
deceased-donor kidney, typically waiting between four and five
years. With nearly 2,000 patients in the queue, D.C.’s transplant
waiting list is the country’s longest, says Melancon. Only one in
four will receive a transplant. And although African-Americans
make up only about 12 percent of the U.S. population, they
represent 23 percent of patients on the waiting list, according to a
report by the U.S. Department of Health and Human Services.
Organ donation, according to Melancon and Jagadeesan,
offers patients the best of both worlds: low cost and better
outcomes. Dialysis — which uses machines to cleanse the
blood — is a big and profitable business. Melancon estimates
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J. Keith Melancon, M.D. (left), and Muralidharan Jagadeesan,
M.B.B.S. (center), convene weekly transplant committee meetings
to discuss the elements of each case, from a patient’s medical
history to current physical and mental health status, as well as the
availability and compatibility of a live organ donor.

ADVANCING ALTRUISM

National Minority Organ and Tissue Transplant Education
Program Joins GW to Raise Organ Donation Awareness

BY STEVE GOLDSTEIN

A

ccording to the U.S. Department of Health and Human
Services, 34 percent of the more than 101,000 people
on the national waiting list for a kidney transplant are
African-American. Overall, minorities account for 58
percent of those on organ transplant lists, but represent just
42 percent of those who receive transplant surgery. AfricanAmericans make up the largest group of minorities in need of a
transplant, at 30 percent, but they make up less than 14 percent
of donors. Due to the greater incidence of diabetes and high
blood pressure among African-Americans, they are more at risk
for organ failure. Organ types are more likely to match if they
come from individuals of the same ethnicity.
Community education is vital in reducing the rate and
number of ethnic minority Americans in need of organ
and tissue transplants. It’s a big part of why, when J. Keith
Melancon, M.D., came to Foggy Bottom in the fall of 2014 to
serve as professor of surgery at GW’s School of Medicine and
Health Sciences (SMHS), chief of the Division of Transplant
Surgery, and director of the Transplant Institute at GW
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Hospital, he brought with him a ready-made community
health organization, the National Minority Organ and Tissue
Transplant Education Program (MOTTEP ®). The partnership is the realization of Melancon’s vision of increasing kidney
donations by raising awareness. MOTTEP’s expertise in the
community helped garner support among District of Columbia
authorities for the new transplant center.
“MOTTEP is a grassroots community organization,”
explains Melancon. “What it has done for GW is identify the
best access for us to reach the people with end-stage renal
disease.” Hospitals, he adds, traditionally don’t know where
to go to interact with the community for health interdiction.
“MOTTEP knows the corporate structure that’s interested in
helping, as well as where citizens tend to congregate and are
open to this kind of discourse about health.”
At a recent community event at a local Safeway grocery
store, scores of D.C. residents received blood pressure tests,
cholesterol checks, weight measurements, body mass assessments, and other health tests. They were also encouraged

that dialysis for one patient costs $80,000 to $100,000 annually, whereas a transplant runs about $30,000. Transplant
patients also have a longer life expectancy.
“Right now, all the advancements in immunosuppression and surgical techniques have improved outcome
significantly,” explains Jagadeesan. The availability of desensitization (reducing antibodies) drugs and ABO-incompatible
transplants — meaning the donor and recipient have different
blood types — means a broader selection of patients can be
transplanted successfully.
So if transplants are better, and more patients who need a
kidney can qualify, why can’t they get them? Simply, explains
Jagadeesan, “it’s a demand and supply problem. The demand for
organs is not met by the supply.”
Since arriving at GW in early 2014, Melancon, with
supportfrom Anton Sidawy, M.D., M.P.H. ’99, Lewis B. Saltz
Chair of Surgery, and professor of surgery at SMHS, has
made it his mission to expand the universe of donors and thus
increase transplantation. To help achieve this goal, Melancon
has engineered a partnership with the Minority Organ and
Tissue Transplant Education Program to inform the minority
community about the facts — and fictions — of kidney donation
(see related article below).

“What I want to concentrate on is helping people in
the hardest-to-transplant areas,” Melancon says, “and it will
translate into more transplants for everyone who is difficult to
transplant. That is my strategy.”
The prospects, he adds, for making a significant improvement in the D.C. community is palpable.
Speaking of palpable — how now to explain the cow?
Melancon’s skill as a surgeon and as an advocate for his
cause seem reinforced by an uncanny perceptiveness about the
challenges ahead. One of his oldest friends, Perry Franklin,
a classmate at Louisiana State University, recalls their first
meeting at a post-high school summer program for minority
students interested in veterinary medicine or health careers.
“We became fast friends,” says Franklin, “and one day we
were being taught how to palpate a cow’s ovaries prior to artificial insemination. Keith was in front of me, but somehow he
slipped behind me in line, and I was next. When I reached in,
the cow explosively ejected my hand and arm and painted me
with [awful stuff].
“Now how did Keith know not to be next in line?”
Franklin laughs.
Perhaps that timely line swap was Melancon’s first
transplant.

to sign organ donor cards. “There’s been a long-standing
suspicion in the African-American community about transplants and the medical establishment,” says Melancon.
“MOTTEP is educating people so that they understand that
if they donate more, there will be more transplants… . We’ve
done numerous events with MOTTEP, and they’ve been very
successful.”
Clive Callender, M.D., who established MOTTEP in
1991, believes Melancon’s efforts are crucial to the organization’s mission and success. “Keith is a tremendous transplant
surgeon,” Callender says, “but what’s special about him is his
real love for the community and his willingness to go into the
community to educate and empower people. He understands
communication, and he has charisma, which makes him effective at reaching all ethnicities.”
MOTTEP, Callender explains, has created community
programs for building relationships and raising community
awareness regarding organ transplant in minority populations
in the Washington, D.C. area. MOTTEP also promotes healthy
lifestyles to prevent kidney disease.
Callender’s strategy to educate and raise awareness about
the need for organ and tissue donation was based on overcoming five obstacles identified through focus groups:
• Lack of community awareness about renal disease
and transplantation

•C
 onflicting religious beliefs
•D
 istrust of the medical community
•F
 ear that signing an organ donor card meant medical
personnel would not work as hard to save them
•B
 elief that their organs would go only to whites
“We have always focused on outcomes,” says Callender, a
clinical professor of surgery at Howard University Hospital,
where he began a local MOTTEP in 1978 with a $500 grant
from the D.C. government to investigate low donor rates
among minorities. “Of course, we wanted attitudes toward
donation to change. But the important thing was to change
behavior, and we have seen donations from blacks more than
double since we started.”
MOTTEP joined with GW Hospital in its application to
initiate a kidney and transplant program, and a certificate of
need was granted in February 2014. A contract with MOTTEP
was signed that same year and runs through 2017. MOTTEP’s
presence at GW includes program director Patrice Miles, an
administrator, and a regional coordinator.
“When I started MOTTEP, many people told me one
person couldn’t change the donation equation for minorities,”
says Callender, who, in New York City’s Harlem neighborhood,
contracted tuberculosis at age 15 and was hospitalized for more
than a year and a half. “My own adversity — and telling me it
couldn’t be done — inspired me to do what seemed impossible.”
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AIMING TO

EDUCATE:
The GW/Ron
and Joy Paul
Kidney Center
BY CAROLINE TRENT-GURBUZ

I

n the epidemic of kidney disease,
the number of people in need
far outweighs those donating.
Washington, D.C., more than any
other city in the United States, has been
at the center of this off-balance issue.
The Ronald and Joy Paul Foundation,
with a $2.5 million gift, is establishing the
GW/Ron and Joy Paul Kidney Center to
address the urgent need for community
awareness of kidney diagnosis, treatment,
and donation.
“Joy and I felt very strongly that if
we could better educate the community, then we could hopefully reduce
the amount of kidney failure,” says Ron
Paul, chair and CEO of Eagle Bancorp
and Eagle Bank. “Should somebody be
in end-stage renal failure, we want to be
able to educate them on transplantation.
It’s all about awareness and education.
That’s what we’re going to be promoting
through this center.”
For Paul, the gift strikes a personal
note. In the 1980s, he was diagnosed
with glomerulosclerosis, a kidney disease
that can eventually end in kidney failure.
“It came out of nowhere,” he says. “I
didn’t have any pre-existing conditions,
no diabetes, no high blood pressure, no
issues at all other than I found out I had
kidney failure.” Eight years later, Paul
faced a decision of a lifetime of dialysis
or a kidney transplant. He chose a transplant, and his brother, Steven, provided
the needed organ. The donated kidney
lasted far beyond its typical lifespan,
but in 2008, Paul learned he would need
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another transplant. Again, he received
a donation, this time from his longtime
friend and chief financial officer of his
company, Kathy McCallum.
“When I had my first transplant in
1990, I had two very young children, I
was starting a business, we had very little
means to be able to support ourselves,”
Paul says. “So, going from being pretty
sick to being energetic and able to run a
real estate company and be chairman of a
bank, it’s a great feeling. But most importantly, now it’s a time to help others.”
Organs from live donors, such as
Steven Paul and McCallum, are ideal;
they shorten or completely eliminate a
patient’s need to be placed on a waiting
list or on dialysis, and the short- and

long-term survival rates tend to be better
than those from deceased donors. With
outreach from the GW/Ron and Joy Paul
Kidney Center, the Pauls are hoping
to tip the balance of kidney supply and
demand, a move that could potentially
save the lives of Washington, D.C.
residents.
That mission of giving back to the
community is one to which Paul ascribes
on a daily basis. Hanging in his office and
at his home is a saying from Winston
Churchill: We make a living by what we
get, but we make a life by what we give.
“That’s what we’ve tried to teach to
our children and family, and tried to live
by,” he says. “It’s pretty powerful if you
can get your arms around it.”

FACULTY NEWS
Rao Rises to Department Chair
Raj Rao, M.D., a nationally recognized authority in spinal
biomechanics, injuries, and fusion, is expanding his expertise;
as the new chair of the Department of Orthopedic Surgery at
George Washington Hospital (GW Hospital) and GW’s School
of Medicine and Health Sciences, he will position the department for clinical and research growth.
“GW Hospital is pleased to have Dr. Rao join our
comprehensive team as the new chair of the Department of
Orthopedic Surgery,” said Barry Wolfman, M.S. ’84, CEO of
GW Hospital. “Dr. Rao’s vital orthopedic research, his commitment to his patients and staff, and his dedication to engaging
with the communities he serves will help us continue GW’s
legacy of progressive leadership. The advanced care that
our established orthopedic team already provides will only
benefit from his leadership and engagement.”
Rao comes to GW from the Medical College of
Wisconsin, where he served as vice chair in the Department
of Orthopedic Surgery and professor of orthopedic surgery
and of neurosurgery. In 2014, Rao was appointed as chair of
the FDA Advisory Panel on Orthopaedic and Rehabilitation
Devices; there, he leads the panel in reviewing the safety
and efficacy of orthopedic and spine-related devices for
marketing in the United States. He was the recipient of the
David Selby Award of the North American Spine Society
in 2014.

Pattern Potential
In the battle against HIV/AIDS, new
research co-authored by Douglas F.
Nixon, M.D., Ph.D., Walter G. Ross
Professor and chair of the Department
of Microbiology, Immunology, and
Tropical Medicine at GW’s School of
Medicine and Health Sciences (SMHS),
points to immune responses as a
potential deciding factor in infection.
According to Nixon’s findings, some
individuals who have been exposed to
HIV-1, but who remain uninfected, have
a different pattern of virus-specific
immune responses from those who
became infected with the retrovirus.
“Research has shown that T-cell
responses can be observed in virally
exposed but uninfected persons,” said

Nixon. “The question that has remained
unanswered is whether or not these
T-cell responses could be protecting
people from acquiring systemic HIV
infection. What we found was … a correlation between future infection risk and
a measurable immune response.”
Nixon and colleagues from the
University of California at San Francisco;
the University of Sao Paulo in Brazil;
and the Gladstone Institutes reviewed
data from the Pre-exposure Prophylaxis
Initiative (iPrEx) trial, the first randomized controlled trial of pre-exposure
chemoprophylaxis (PrEP) in humans.
Remaining specimens from the trial
were used to test for naturally acquired
or induced immunity to HIV-1 infection. The team discovered that those

who became infected typically lacked
responses to two HIV-1 proteins. The
findings, published in the Proceedings
of the National Academy of Sciences,
suggest that such immune responses
may play a role in blocking systemic
infection after exposure to the virus.
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FACULTY NEWS
The Wright Stuff
Karen Wright, Ph.D., PA-C, was selected to serve as the
interim chair and program director of the Department of
Physician Assistant Studies at the GW School of Medicine
and Health Sciences.
Wright brings more than 28 years of experience as a
physician assistant (PA) to the position, and much of her
career has been dedicated to the education and development of future PAs. She has been a member of the GW
faculty since 2008 and has served in a leadership role as
the director of research, program evaluation, and admissions. Wright also served as the associate program director
during the reaccreditation process. GW’s PA program is one
of the top-ranked PA programs within the United States and
recently earned reaccreditation for a full seven-year term.

Doctor–Editor
Gaetano
Lotrecchiano,
Ed.D., Ph.D.,
assistant
professor
of clinical
research and
leadership
and of pediatrics at GW’s School of Medicine and
Health Sciences, is branching out to add
“associate editor” to his list of titles. On
July 1, 2015, Lotrecchiano assumed his
new role at the Journal of Collaborative
Healthcare and Translational Medicine
(JCHTM), formerly published as the
Journal of Translational Medicine and
Epidemiology.
The international peer-reviewed
journal is dedicated to the advancement
of research, science, editorial, review,
and practical applications in the areas
of translational health care and medicine. In addition to “bench to bedside to
market” processes, the JCHTM strives
to highlight the collaborative aspects
of translational science through the
contributions of team science research,
social and behavioral science, economic
and technological inquiry, and the
experience of health and biomedical
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professions involved in translational
health and medical sciences.
“I am honored and humbled by
the opportunity to serve in this role
within the JCHTM,” Lotrecchiano said.
“Contributing to science is very important to me as a professor and a scholar.
My goal is to lead the JCHTM to offer
commentary, research, and communications to an audience of medical and
health care researchers, practitioners,
and policy-makers through the presentation of relevant and high-quality
scholarship.”

Akman Joins PACHA
Jeffrey S. Akman, M.D. ’81, RESD ’85,
vice president for health affairs at
GW, Walter A. Bloedorn Professor of
Administrative Medicine, and dean of
GW’s School of Medicine and Health
Sciences, was sworn in as a new member
of the Presidential Advisory Council on
HIV/AIDS (PACHA) on May 21, 2015.
As part of PACHA, Akman, who has
treated patients living with HIV since the
beginning of the epidemic, will work with
local and national community leaders, as
well as leaders from science, medicine,
public health, business, and philanthropic organizations to provide advice,
information, and recommendations

on HIV-related issues and policies to
the Department of Health and Human
Services and the White House.
“I am thrilled to be a part of this
important group,” said Akman. “As
a psychiatric physician, I understand
the importance of sound national and
federal HIV/AIDS policy and its implications for the delivery of care and overall
well-being for many patients with HIV/
AIDS and those at high risk for the
disease. I look forward to working with
my colleagues on this council as we help
guide our nation’s top leaders in making
informed decisions related to HIV/AIDS.”
For many years, Akman has been
advising physicians, research institutes,
and medical organizations on the need
for mental health and substance use
care to be included when treating HIV
patients. In his role as an advisor, he
served as the principal investigator for
a NIH grant to train health care professionals in the medical and mental health
aspects of HIV/AIDS.
He has provided leadership and
advisement for many prestigious HIV/
AIDS-related initiatives, including the
American Psychiatric Association’s first
commission on AIDS. He also served on
the Mayor’s Commission on HIV/AIDS
and chaired the commission’s Treatment
on Demand Committee.

Nitric Oxide 1, Acne 0

In the Name of
Student Support
Katherine Chretien, M.D., associate
professor of medicine and new
assistant dean for student affairs for
GW’s School of Medicine and Health
Sciences, is bolstering support for
students navigating their medical
education and career prospects.
As a member of the dean’s executive leadership team, Chretien, in her
new role, will participate in the development and operation of an accredited
undergraduate medical education
program. She also will develop a career
counseling program and a system
for access to health services; prepare
the Medical Student Performance
Evaluation for senior medical students;
and provide leadership in the development of programs and policies
designed to foster the academic,
personal, and career success of a
diverse student body.
Additionally, Chretien will participate in the student admissions process,
including interviewing and reviewing
files of potential students, as well as
assisting with the planning and implementation of strategies leading to
successful accreditation of the undergraduate education program.

Chalk up another entry on the list
of medical ailments that nitric oxide
treats. The cellular signaling molecule
is already associated with the treatment of conditions such as pulmonary
hypertension and acute respiratory
distress syndrome, and it plays a key
role in the function of medication
for erectile dysfunction. Now, GW
researcher and dermatologist Adam
Friedman, M.D., has discovered that
the release of nitric oxide over time
may effectively treat and prevent
acne. The research, published in the
Journal of Investigative Dermatology,
suggests that nitric oxide nanoparticles are effective at killing the bacteria
associated with acne. More importantly, the nanoparticle treatment
inhibits the damaging inflammation
that results in the large, painful lesions
associated with inflammatory acne.
“Our understanding of acne has
changed dramatically in the last 15
to 20 years,” said Friedman, associate professor of dermatology at
GW’s School of Medicine and Health
Sciences and co-author of the study.
“Inflammation is really the driving force
behind all types of acne.”
The study focused on a recently
identified pathway known as an
inflammasome, responsible for
the activation of the inflammatory

process in acne. Friedman and
colleagues from Albert Einstein
College of Medicine and the
University of California at Los Angeles
determined that nitric oxide served
as an effective means of killing the
bacterium that causes acne without
using an antibiotic. They also found
that its use inhibits the inflammasome
pathways central to the formation of a
pimple before it is even visible.
“By killing the bacterium and
blocking multiple components of the
inflammasome,” explained Friedman,
“this approach may lead to better treatment options for acne sufferers, and
possibly treatments for other inflammatory skin conditions.”

Margaret Plack Named CRL Interim Chair
Margaret M. Plack, Ed.D., DPT, PT,
has been named interim chair of the
Department of Clinical Research and
Leadership (CRL) at GW’s School of
Medicine and Health Sciences. In her
new position, Plack will oversee and
provide leadership support for the
department’s 12 programs.
With more than 25 years of experience in both academic and clinical

practice, Plack, a professor of physical
therapy and health care sciences,
brings outstanding credentials to the
stewardship of CRL. A longtime leader
at SMHS, she has served as the director
of the Physical Therapy program, chair
of the Department of Health Care
Sciences, and interim senior associate
dean for health sciences since joining
the faculty in 2004.
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FACULTY NEWS

The “Kick and Kill” Strategy
GenerationCURE, a group of young
professionals dedicated to supporting
the cure-focused research of the
American Foundation for AIDS
Research (amfAR), recently awarded its
inaugural $180,000 research grant to
Brad Jones, Ph.D., assistant professor
in the Department of Microbiology,
Immunology, and Tropical Medicine’s
Research Center for the Cure and
Eradication of HIV in at GW’s School of
Medicine and Health Sciences. Jones is
employing an innovative approach to
HIV treatment.
“It’s a terrific honor to have our
work recognized by generationCURE,
and we will be working especially
hard to deliver impactful results that
are worthy of the effort they put into
this unique fundraising initiative,” said
Jones. “If successful, our work will set
the stage for clinical testing of novel,
potentially curative HIV therapeutics.”
Jones and his colleagues are
exploring whether a novel combination therapy can eradicate the latent
reservoirs of HIV that present a major
barrier to finding a cure. Although
antiretroviral therapy can reduce active
HIV to undetectable levels in the blood,
it cannot reach dormant HIV in cells,
which can reactivate and replicate
at any time. The team will employ a
strategy known as “kick and kill” to
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attack this reservoir. Many researchers
using this approach have been challenged by their patients’ immune
systems’ inability to kill the cells
infected with the reactivated virus.
Jones hopes to overcome this
challenge by using a drug that
increases the activity of a protein
known as TLR2 (a TLR2 agonist). They
have previously shown that the TLR2
agonist can reactivate — or “kick” — the
latent HIV in infected cells, while
simultaneously boosting the ability of
a patient’s own cytotoxic T-cells to kill
those infected cells.

The “Low-T” and
Depression Link
Researchers at GW, led by Michael S.
Irwig, M.D., found that men referred
for tertiary care for borderline testosterone levels had much higher rates of
depression and depressive symptoms
than those of the general population.
“In an era where more and more
men are being tested for ‘Low T’ — or
lower levels of testosterone — there is
very little data about the men who have
borderline low testosterone levels,” said
Irwig, associate professor of medicine
and director of the Center for Andrology
at GW’s School of Medicine and Health
Sciences. “We felt it important to explore
the mental health of this population.”
The research, slated to be
published online in the Journal of
Sexual Medicine, focused on 200 adult
men, aged 20–77 years, who were
referred for borderline total testosterone levels between 200 and 350
ng/dL. Depression and/or depressive
symptoms were present in 56 percent of
the subjects. Furthermore, one-quarter
of the men in the study were taking
antidepressants and had high rates
of obesity and low rates of physical
activity. The most common symptoms
were erectile dysfunction, decreased
libido, fewer morning erections, low
energy, and sleep disturbances.

Although more research is needed
in this area of study, the researchers
concluded that clinicians should
consider screening for depression and
depressive symptoms, overweight, and
unhealthy lifestyle factors in men who
are referred for tertiary care for potential hypogonadism.

Listening and Learning
Collaboration between health care
professionals, researchers, and institutions is quickly becoming the name
of the game; to that end, Ashkan
Monfared, M.D., associate professor
of surgery and neurosurgery at the
GW School of Medicine and Health
Sciences, and his colleagues from
Global ENT Outreach, El Centro de
los Sentidos, and Clinica de Marly
hosted the first Advanced Otology
and Temporal Bone Course in Bogota,
Colombia. The two-day, hands-on
course provided instruction for complex
otologic surgeries that can cause potentially devastating morbidity in patients.
“It was a great opportunity to
work with these medical trainees in
Colombia and assist in sharpening their
surgical skills so they can significantly
improve outcomes for patients with
otologic disorders,” said Monfared,
who served as a course faculty member
with support from the Ruth Uppercu
Paul Fund for Hearing Health and
Rehabilitation. “The response from the
group was overwhelmingly positive, and
they asked for additional opportunities
for training. It’s our goal to offer this
course twice per year and to extend the
hands-on section by an extra half day.”
In addition to his work with the
course, Monfared helped develop the
mission for a charitable hearing health
organization founded by one of the
course leaders, Martin Fernandez, M.D.
Monfared will coordinate the efforts
between GW and the organization — the
first of its kind in Colombia — and serve
on its board of directors.

Leadership in Research

Edward Seto to Spearhead Basic
Sciences at GW Cancer Center
The newly established GW Cancer Center, with director
Eduardo Sotomayor, M.D., at the helm, has tapped Edward
Seto, Ph.D., as the associate director for basic sciences.
Seto, an internationally recognized scientist and leader in
cancer epigenetics, will spearhead the center’s ongoing
development, implementation, and evaluation of basic
science-related programs and initiatives.
“I am thrilled that a basic scientist and a leader of the
stature of Ed Seto has joined the GW Cancer Center team.
He is the kind of scientist that every major cancer center
would love to have. We are very pleased that among all the
cancer centers that he was enticed to join, Ed has chosen the
GW Cancer Center to continue with his extremely productive
scientific career,” said Sotomayor, who also holds the position of professor of medicine at GW’s School of Medicine
and Health Sciences (SMHS). “Ed and I, along with the senior
leaders of GW, the GW Medical Faculty Associates, and
GW Hospital, shared the same vision that strength in basic
science is fundamental for the building of an innovative
cancer research enterprise.”
Seto’s additional responsibilities include collaborating
with other associate directors of cancer centers — particularly
those specializing in clinical investigation, population science,
administration, and education, among others — to integrate all
programs, and identifying areas that could become potential
scientific programs and part of the National Cancer Institute
designation grant application. Seto will also serve as professor
of biochemistry and molecular medicine at SMHS.

Award-winning neuroscientist and published researcher
Robert H. Miller, Ph.D., attributes much of his success to
honing his approach to science.
Becoming a scientist “is asking important questions
that are practical and designing experiments that give you
unambiguous answers,” said Miller, senior associate dean for
research and professor of anatomy and regenerative biology
at the GW School of Medicine and Health Sciences (SMHS).
“If you can do that, you can do science.”
Miller’s words came as part of his formal installation in
May 2015 as the Vivian Gill Distinguished Research Professor.
The professorship was created in 1967 by a gift from Thomas
H. Gill in memory of his wife, Vivian. Miller joined past
distinguished Gill professors David Reiss, former professor
of psychiatry and behavioral sciences, of medicine, and
of psychology at SMHS; and Steven R. Patierno, adjunct
professor of pharmacology and physiology at SMHS.
Miller joined the SMHS faculty in June 2014, having
previously served as the vice president for research at Case
Western Reserve University.

Save the Date!
ALUMNI WEEKEND 2016

September 30 thru October 2
We look forward to celebrating
the M.D. Program classes of

1966, 1976, 1981, 1986,
1991, 1996, and 2006
Get involved now by contacting
smhsalumni@gwu.edu or (202) 994–7511

See you back at Ross Hall soon!
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BY CAROLINE TRENT-GURBUZ

W

hen it comes to higher education in the United
States, cost can be a serious impediment for
ambitious students, especially those seeking
to carve out careers in medicine and the health
sciences, the Association of American Medical Colleges
reports. Compounding increasing costs are additional years
of residencies and internships, at times compelling soon-to-be
clinicians to make specialty decisions based on finances, rather
than desires. In an effort to ease those pecuniary burdens,
GW’s School of Medicine and Health Sciences (SMHS) has
established, and continues to explore, new avenues of financial
support.
“It is vital that our students, tomorrow’s leaders in medicine and the health sciences, are not limited when it comes to
serving their communities,” says Jeffrey S. Akman, M.D. ’81,
RESD ’85, vice president for health affairs at GW, Walter A.
Bloedorn Professor of Administrative Medicine, and dean of
SMHS. “That is why we continue to prioritize current-use and
endowed scholarships, as well as additional philanthropic aid.”

ADOPT-A-DOC

Daegu, South Korea, native Jiyong Lee, M.D. ’15, didn’t expect
to receive a scholarship before attending SMHS; as an international student, he wasn’t even eligible for federal loans. His first
year at GW, however, he and Allison Hoff, M.D. ’15, became
the first recipients of the then nascent scholarship program
“Adopt-a-Doc.”
Adopt-a-Doc began with a gift from Russell Libby,
M.D. ’79, assistant clinical professor of pediatrics at SMHS,
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who donated funds in memory of his mother, Leona Libby
Feldman. The idea of the gift — a minimum of $20,000 to be
spread equally over a four-year period — was to make both
an immediate and lasting impact on students’ debt burden,
including on the accumulation of compounding interest, while
ensuring donors knew the student who was benefiting. “I feel
good knowing that the contribution has a name and a face
and is [meant for] someone for whom I can potentially act as a
mentor,” Libby said at the time of his donation.
Sandra Caskie, M.D. ’82, also pledged a gift in memory of
a loved one: her former classmate and close friend, Henrietta
Leonard, M.D. ’82, RESD ’85, a Rhode Island–based psychiatrist who died in 2007. Caskie’s gift went to Lee, Libby’s to
Hoff, who is now a resident at the University of Maryland
Medical Center.
For Lee, the gift was invaluable, allowing him to focus
on primary care medicine, a field typically less lucrative than
others. “The second I got a call from Dr. Caskie, I had less
of a burden than other people, and I could pursue a career in
primary care, which I really wanted to do,” says Lee, a resident
at Dartmouth-Hitchcock Medical Center in New Hampshire.
“Sometimes other students don’t have that opportunity, and
they try to divert their paths to the more specialized fields for
a better income. This scholarship provided me room financially, and Dr. Caskie encouraged me to pursue my career in
primary care.”
Since its inception, Adopt-a-Doc has grown to include
nearly two dozen scholarships. One contributor, Tom Flynn,
M.D. ’86, is supporting five medical students, and the SMHS

Class of ’87 banded together to provide support to a member of
the next generation of physicians.
To learn more about becoming involved in the program,
contact Sumana Chatterjee, director of development, at
schatter@gwu.edu or (202) 994-6724, or visit smhs.gwu.edu/
give/power-of-giving/adopt-a-doc-scholarship.

WHITE COAT INITIATIVE

The white coat, though simple in design, is an iconic symbol
for those in health care; when they don their coats for the first
time — a passage treated with ceremony and respect — medical
and health sciences students are reminded of their commitment
to, and passion for, healing. Putting on the coat also signifies the
start of a career and the responsibility and trust that decision
entails.
In recognition of that milestone, the White Coat Initiative,
which started in 2001, allows SMHS alumni to forge relationships with students entering the field, acting as a welcome to
the professional community. For medical students, alumni’s
financial support provides for white coats, supplies used during
Community Service Day, and educational technology and software, in addition to other activities. More recently, in the fall
of 2014, the White Coat Initiative helped to provide incoming
medical students with iPads and iPad minis, part of an SMHS
transition toward a paperless curriculum and more accessible
program materials. The White Coat Initiative was extended
two years ago to physician assistant (PA) students, who receive
their long white coats at a pre-graduation ceremony.
“It is truly reassuring that I am following in the footsteps
of qualified, driven, well-educated GW alumni,” says Elizabeth
Prevou, PA-C ’15, M.P.H. ’15. “To have them as part of my White
Coat Ceremony, and to wear a white coat gifted by one of them,
is a reminder for me to keep perspective, continue persevering,
and honor my chosen profession.”
For more information on the M.D. White Coat Initiative,
please contact Lisa Harter at lwharter@gwu.edu.
For more information on the PA White Coat Initiative,
as well as for information on options for physical therapy and
other health sciences students, please contact Sarah Klein at
smklein@gwu.edu.

ENDOWED SCHOLARSHIPS

Each year, SMHS provides more than $5 million in support;
close to 75 percent of students receive funds. Of those, around
half receive private philanthropic aid. Endowed scholarships — which total close to 80 — offer considerable funding
opportunities for students. Some provide general support for
students in medicine and the health sciences, whereas others
are more tailored to the interests of the donors. The Ella F.
Andrews, the Anna Bartsch, and the Hazel Mae Bayne, M.A.
’30, B.A. ’25, Scholarship Funds, for example, provide assistance

The George Washington University School of Medicine and
Health Sciences (SMHS) held a special reception in Sag Harbor,
New York to benefit SMHS organizations, The Research Center
for the Eradication of HIV and The Rodham Institute for Health
Care Provider Education to Eliminate Disparities, at the home of
John D. Evans and Steve Wozencraft on Aug. 29.
The event, principally sponsored by the John D. Evans
Foundation, as well as Sisley Paris, Royal Asscher, and the
Cyrus Katzen Foundation, featured a welcome from host John
Evans followed by remarks from Jeffrey S. Akman, M.D. ’81,
RESD ’85, vice president for health affairs, Walter A. Bloedorn
Professor of Administrative Medicine, and dean at SMHS, as
well as Douglas F. Nixon, M.D., Ph.D., Ross Professor of Basic
Science Research and chair, Department of Microbiology,
Immunology, and Tropical Medicine at SMHS; and Jehan
El-Bayoumi, M.D., RESD ’88, founding director, The Rodham
Institute and professor of medicine at SMHS.

to female students; the Henry and Mary Amster and Louise
Greenburg Amster Scholarship Endowment in Medicine,
on the other hand, awards funding to those with an interest,
knowledge, and commitment to the Jewish community.
Additional scholarships target students specializing in specific
fields, such as radiology or health care delivery, and the Eugene
B. Casey Scholarship Fund provides four years of full tuition,
room, and board.
“Here at GW, we know the bedrock of our mission is
educating and training the next generation of physicians and
healers,” says Dennis Narango, M.A., CFRE, associate vice
president and associate dean at SMHS. “The bottom line is
that we need a robust scholarship program in order to attract
the best and the brightest.”
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I

n the coastal town of Santa Maria, California, about three
hours northwest of Los Angeles, the Shepard family —
Dennis, Franziska, Daniel, and Nancy — regularly gathered
at the dinner table to discuss the practice and business of
medicine. It was a tradition that Dennis Shepard, M.D. ’63,
traces back to his wife’s childhood in Vienna, Austria.
“She was raised in the hotel and restaurant industry, and
they were all wonderful cooks, unbelievably good,” Dennis
recalls. “They cooked a lot and would eat a lot, and … everyone
sat around and talked. This passed onto me.”
Although he hesitates to use the term “push,” Dennis
believes that the dinner table conversations steered his children
toward the service industry; Nancy became a lawyer, and Daniel,
M.D. ’96, M.P.H. ’96, followed his father’s lead into medicine.
“I feel like I have an unusual perspective because I have an
institutional view of medicine that goes back almost 50 years
now,” Daniel says. “We were talking about everything from
diagnostic techniques to governmental policy and billing practices, at a very early age. That was dinner table conversation.”
Both Dennis and Daniel — a unique pair of father-son GW
School of Medicine and Health Sciences (SMHS) alumni —
specialized in ophthalmology, though as Daniel explains, their
drives for medicine were different. “My father, in addition to
providing quality medical care to the patients in the community, was looking for a type of notoriety,” Daniel explains. “He
wanted to make a splash. I’ve had a little more internal motivation. I have been, for want of a better term, an adrenaline
junkie for all of my life.”
It’s an assessment that Dennis agrees with. The elder
Shepard’s path into medicine started in childhood, when his
mother suggested he go into a profession where he could “wear
a white coat,” rather than follow the family business of farming.
Dennis eventually enlisted in the military and served as a
combat medic during the Korean War. He was also stationed in
Vietnam and Japan, and his career led him to running MASH
units and building walk-in clinics. When it came to applying
to medical school, however, Dennis hit a bump. He applied to
fewer medical schools than his peers, and an early struggle with
math affected his GPA. Dennis’s mother called Howard Stern,
the Shepard family doctor who had ties to GW, who “put in a
good word for me,” Dennis says.
“I owe a lot to GW because they accepted me when
nobody else would even give me an interview,” he explains. “It
made a total difference, 100 percent difference, in my life. It
permitted me to be a doctor.”
Dennis became a prominent surgeon and ophthalmologist who pioneered development in intraocular lenses and
refractive surgery. In 1967, he founded the Santa Maria-based
Shepard Eye Center, one of the largest private eye clinics in the

world. A little over a decade ago, the Shepard Eye Center and
Kendall Optometry merged and opened a second facility, the
Kendall-Shepard Eye Center, in Lompoc, California. Dennis
has garnered awards, such as the GW Alumni Service Award
in 2001, and held multiple leadership positions. In short, he has
made a splash.
For Daniel, the family business made for a natural transition. He started as a work-up technician at the Shepard Eye
Center, and by age 14, he was passing instruments to his father in
the operating room. He earned his EMT certificate before even
earning a high school diploma, and he put together a first-aid
crew in college. At GW, he became one of the few in his class to
earn his Master of Public Health degree with his M.D. degree.
“The big drives have been one, kind of the adrenaline
junkie,” he says, “and two, whatever I could do to distinguish
myself from the crowd.”
Daniel toyed with the idea of pursuing pulmonary critical
care before committing to ophthalmology, specifically retinal
surgery. Retina, he explains, has that adrenaline element.
“Retinal detachment, neovascular glaucoma, endophthalmitis,
penetrating eye trauma and foreign bodies; these are the bailiwick of the retina surgeon, and these demand an availability and
willingness from the doctor to deal with them at any hour and
for as long as it takes to resolve the issue,” he says. “The sense
of precarious urgency, and the need that I fill by being here to
provide such care in unpredictable situations, creates a satisfying
adrenaline rush whenever such a case comes through my door.”
Even though he and his father are in ophthalmology, he
adds, they’re not in competition. “There were some very interesting discussions when I could bring new information to the
table because of my interest in retina, beyond what [my dad]
had been doing,” Daniel says. “We had a lot of fun doing that.”
With the Shepards firmly established in the medical
world, they recently decided to give back to the institution
they credit with their initiation into general medicine. “We’ve
got a long-term relationship with the university,” says Daniel,
who now holds an active faculty appointment and a visiting
lecturer role with the Department of Ophthalmology at
SMHS. “We found ourselves in a position where we had the
opportunity to give back.”
And so, with help from Franziska and her well-developed
business acumen, the Shepard Professorship gift was created.
Although the gift is still in an “incubation process,” Daniel
explains, it will go toward the ophthalmology department. “We
are looking forward to seeing what the medical school and the
department are going to do with these resources,” Daniel says,
adding that he cherishes the time he spent at GW.
Dennis echoes his son’s sentiments: “I owe everything to
GW, and that’s where my heart of the gift comes from.”
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of being a doctor for a professional sports
team: You do not talk about the team. To
be more precise, you do not talk about
the athletes you treat on the team. The
wrong word about a player’s health could
hurt far more than any sprain, strain, or
break. This is something Sanjay Menon,
M.D. ’06, learned quickly as he began his
career in sports medicine.
“Athletes are very sensitive about
how their stories and interactions are
portrayed ... there’s suspicion about team
doctors,” says the 36-year-old son of
Indian immigrants. Based at Suncoast
Medical Clinic in St. Petersburg, Florida,
Menon is the team physician for the
National Football League’s Tampa Bay
Buccaneers and an orthopedic consultant to Major League Baseball’s Tampa
Bay Rays and the North American
Soccer League’s Tampa Bay Rowdies. “I
want any athlete I work with to know I
work for them and not anybody else.”
As a cautionary tale, he cited the
example of a well-known sports medicine surgeon who was incompletely
quoted about a surgery performed on a
star college quarterback. The player’s
NFL draft value plummeted and the
player never forgave his doctor.
“If athletes know I have their best
interests in mind professionally, they will
be confident that I’m watching out for
them medically, too,” Menon explains.
In the high-stakes world of professional
sports, being a skilled physician, like
being a gifted athlete, is not enough.
Though he’s the son of a successful
orthopedic hand surgeon who designed
the modern-day wrist replacement,
Menon initially tried a different
career tack. A music and humanities
major at the University of Southern
California, Menon sang in a rock band
and worked as a trainee talent agent
for the Endeavor agency, headed by Ari
Emanuel, who was immortalized in the
fictional TV series “Entourage.” “One

of the greatest skills you learn in that
business is communication,” explains
Menon. “Physicians are often faulted
for not communicating well.”
Ultimately, medicine lured him
back, and Menon enrolled in a postbaccalaureate, premedical program at
Scripps College in Claremont, California,
where his high achievement ensured an
interview at GW’s School of Medicine
and Health Sciences (SMHS). That
brought him east to Foggy Bottom and
a literal love affair at SMHS. He met his
wife, Amy Strickland, M.D. ’06, at med
school, and before long their classmates
made up nearly a third of their wedding
guest list. Strickland is now the gastroenterologist for the Tampa Bay Rays, so
whether it’s your bones or your belly that
is aching, the Strickland-Menon family
has you covered, they joke.
“I’ve always felt I was extremely
well prepared by the teachers at SMHS,”
Menon says with pride. “That helped
me get into a good residency program
at Los Angeles County Harbor–UCLA
Medical Center.” The springboard
into sports medicine was a prestigious
one-year orthopedic fellowship with the
legendary James Andrews, M.D., one of
the most innovative sports surgeons in
the world. Andrews mentors dozens of
jock docs, including Menon.
Menon’s 2011–12 fellowship took
him to the Andrews Institute in Gulf
Breeze, Florida, which features a highlevel sports fitness facility where many
elite athletes rehab or train. He got
his first college exposure during that
period as a team physician for Auburn
University. Studying at Andrews put
Menon “on the radar” with pro teams,
as did working with elite high school
football teams and having a connection
with a former Andrews fellow working
with the Tampa Bay Rays.
“So by taking care of athletes and
being available, [you encourage] people
[to] think of you when positions open,”
says Menon.
Menon is busy on and off the playing

field, regularly seeing patients at the
Suncoast clinic. “When it comes to an
injury, you treat everyone the same,” he
explains. “One of my mentors would say,
‘Don’t get fancy.’ With athletes, however,
the timeline [for repair and recovery]
may get compressed. For an athlete there
may be less of a role for conservative
care, depending on the injury and the
remaining schedule.”
Sports medicine requires Menon to
stay up to date with innovative therapies, particularly the use of biologics
such as stem cells and PRP (plateletrich plasma) — treatments that can
speed healing. Injury types vary with
each sport, however. Football players
suffer more acute injuries, such as ligament tears and dislocations, whereas
baseball produces more chronic overuse
injuries from early specialization in a
single sport. Baseball is rife with cases
of the so-called Tommy John surgery
for pitchers who have worn out or torn
the ulnar collateral ligament in their
elbows. Among soccer players, Menon
sees both overuse and acute injuries.
The resiliency and determination of
athletes continues to impress Menon. He
cites the example of a Rays pitcher who
underwent Tommy John surgery a year
ago. While participating in the extensive
rehab, and essentially putting his life and
career on hold for more than a year, the
pitcher suffered a major setback during
a throwing session when his medial
epicondyle tore off. Another surgery with
a lengthy rehab was required.
“What was so remarkable was how
composed and deliberate the player was
about the whole event,” Menon recalls.
“The hallmark of a true professional
competitor is seeing each challenge as
just part of the game. He told me he was
ready to get the procedure done so he
could get back to where he needed to be.”
Menon’s job is to get players back
on the field — not to talk about it. He
admires his patients. “The best thing
about working with athletes is their
drive and their love of sports,” he says.
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IT’S GENETIC:

Mother and Daughter
Pursue a Health Sciences
Education Track Together
BY CAROLINE TRENT-GURBUZ

A

s a student, Emily Kavanaugh started down the
path of nursing, picking up fundamental courses as
she strode toward her future. But two consecutive
summer internships tempted her off the trail.
“Since about 2007, when I first interned at a clinical
research facility, I knew that I wanted to do something with
research,” says Emily. “It fascinated me.”
The research during her internships, she explains,
focused on Alzheimer’s disease. One patient, “Shep,”
showed signs of progress; the first summer Emily was there,
he didn’t recognize his family, but by the second summer, he
was chatting about his granddaughter. “That was my turning
point: realizing that you have a direct impact on someone’s
life in that way for future generations,” Emily says. Not long
after, she decided to enroll in the online bachelor’s degree
completion program in the Clinical Research Administration
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(CRA) track at GW’s School of Medicine and Health Sciences
(SMHS). And she wasn’t alone.
Gina Kavanaugh, like her daughter, was on a nursing
path. After many years working as a registered nurse, Gina
made the jump to research. “I’ve been involved in clinical
research for 15 years,” Gina says. “That’s really where my
love has evolved.” As she ascended in her field — rising to
director of research at the facility where Emily interned —
Gina realized further career advancement required earning
her bachelor’s degree in clinical research. In an industry as
degree-conscious as clinical research, there is a constant
demand to keep pace through higher education and
ongoing training. Gina, like Emily, enrolled in GW’s Bachelor
of Science in Health Sciences degree program in CRA.
“When I started out in the field, there was very little
formal training for a coordinator,” explains Gina. “Most of the
education on the process was provided by the pharmaceutical companies conducting the trials. I was very excited to
find such an excellent program of study at GW.”
The SMHS program focuses on drug development and
the various aspects of managing clinical trials and outcomes.
It’s a profession, says Joan Butler, Ed.D. ’09, program
director for the academic undergraduate and graduate
online CRA programs and assistant professor in the
Department of Clinical Research and Leadership at SMHS,
that appeals to those passionate about research.
“One of the overriding aspects that really draws
students to this career is the fact that they’re helping patients
by discovering new treatments and therapies that allow them
to effectively treat their unmet medical needs,” says Butler.
Gina and Emily Kavanaugh describe their experience as
classmates in the program with the same word: awesome.
The two are friendly competitors of sorts; academically,
they strive to outdo each other on tests and assignments,
and Gina’s grade point average is one-tenth of a point
higher than Emily’s — for now. They also rely on each other’s
strengths. “The whole online learning [approach] was a bit
of a learning curve within itself,” Gina says, “so I was really
hoping [Emily] would be able to help me make that transition
and get back into that mindset of school.”
The program has allowed the two to remain in greater
contact, though they live on opposite sides of Virginia:
Gina is in Newport News, where she’s now the director
of research and discovery for Riverside Health System;
Emily, a college recruitment representative at the Jefferson
College of Health Sciences, lives in Roanoke. The two talk
shop whenever they can — even at holiday dinners, much to
the family’s dismay.
With their first year completed, Emily and Gina are
contemplating future plans, but more immediately, they’re
anticipating the graduation ceremony. “That’s the one thing
we’re really looking forward to,” Emily says. “I think that
would be so special [to do together].”

CLASS NOTES
From GW to Southeast Asia
SMHS alumnus taps into clinical and
FDA expertise to help nations in Southeast Asia
implement medical device regulatory regimes
BY CAROLINE TRENT-GURBUZ

S

tuart Portnoy, M.D. ’91, RESD ’92, has just returned
from a trip to Germany and Austria with his family.
His itinerary is colorful and neatly laid out in a document on his laptop, though he clicks from it to other
items, including a map of another trip, this one to Vietnam
in April. The September before he was in Malaysia, and a
year before that his destination was Singapore. This latest
passage abroad was personal; the others, business.
“It’s so much fun for me to be [in Southeast Asia],”
Portnoy says, “and I love traveling.”
Although his trips are recent, the story behind them
stretches back years. Portnoy’s journey began as a young
student. “From the time I was at GW medical school — I’d
already studied chemical engineering as an undergraduate
— I knew during Year One that I wanted to do something at
the intersection of medicine and technology,” he says.
With that convergence in mind, Portnoy wrote GW to
delay his enrollment by one year so that he could study
biomedical engineering in Israel. GW said yes.
“It was so refreshing,” Portnoy recalls. “I knew by the end
of that year that I wasn’t going to be a traditional physician.”
When Portnoy returned to the United States, he settled
into the GW environment but took another yearlong break,
this time to earn a master’s degree in bioengineering at the
University of Pennsylvania. “I loved it so much,” he says.
As both an M.D. and an engineer, Portnoy took what he
describes as a “unique career path.” He spent eight years
with the U.S. Food and Drug Administration (FDA) before
turning to consulting with Biologics Consulting Group; his
area is medical device regulation for cardiology-specific
instruments. With his extensive clinical and FDA-based regulatory experience, Portnoy became an appealing candidate
for the missions that would take him overseas. That story
begins about two decades ago.
Back in the 1990s, according to Matthew Hein,
international trade specialist for the U.S. Department of

Commerce’s International Trade Administration (ITA), the
European Union, Canada, Australia, Japan, and the United
States formed the Global Harmonization Task Force on
Medical Devices (GHTF), which created guidance documents for medical device regulatory regimes. Southeast
Asia, lacking established regimes, became a region of great
interest. As a result, the Association of Southeast Asian
Nations began to implement its systems using both the
GHTF documents and guidance from international regulators — including FDA alumnus Portnoy.
“It’s a perfect partnership between people like me, an
FDA alum, and what the Department of Commerce and the
host nations are looking for,” Portnoy says.
He visited Singapore separately in 2013 to consult about
his experience with FDA and then joined the ITA initiative.
In 2014 and 2015, he went to Malaysia and Vietnam, respectively, to present at ITA-organized workshops with other
industry trainers. In Vietnam, Portnoy spoke about clinical
evidence, although the learning and valuable interactions,
he says, went both ways.
“I think the best part is spending time with my peer
group,” Portnoy says. “People who I didn’t know before that
I really love to talk shop with, talk professional, talk families,
talk about what companies they’ve worked at before. That’s
number one. Number two, I am learning. I am learning new
things all the time, which is great for me.”
Portnoy intends to return to Southeast Asia, where he’s
enthusiastic about the regulatory regime developments. “It’s
a win-win-win, no matter how you look at it,” Portnoy says. “I
just love it from start to finish.”
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CLASS NOTES

Leading the Pack

1950s

Denice Cora-Bramble, M.D., M.B.A., B.S. ’76, FAAP, was
named executive vice president and chief medical officer for
ambulatory and community health service and senior vice
president for the Goldberg Center for Community Pediatric
Health at Children’s National Health System. In her new role,
Cora-Bramble leads all the regional ambulatory clinical
operations; oversees a $113 million budget; and guides
physicians, nurses, and administrative staff members. She
also heads the physician business enterprise at Children’s
National, as well as the strategic alliance and vaccine group
purchasing contracts, among other responsibilities, with
the Children’s National Health Network, a provider group of
more than 1,400 community-based pediatricians.
Cora-Bramble, a professor of pediatrics at the GW
School of Medicine and Health Sciences, has held leadership roles at both GW and the U.S. Department of Health
and Human Services. She is a diplomate of the American
Board of Pediatrics, and in 2007, she received the highest
national honor in community pediatric education, the
Academic Pediatric Association and the American Academy
of Pediatrics’ National Pediatric Community Teaching Award.

Adolphe C. Kiczales, M.D. ’55, A.A. ’49, recently retired after
55 years practicing psychiatry. He and his wife, Barbara, live
in West Virginia.

1960s

Vincent T. DeVita Jr., M.D. ’61, Hon. ’84, co-wrote The
Death of Cancer (Sarah Crichton Books, 2015) with his
daughter, Elizabeth DeVita-Raeburn. The former director
of the National Cancer Institute, former physician-in-chief
at Memorial Sloan Kettering, director of the Yale Cancer
Center, former president of the American Cancer Society,
and developer of the first successful chemotherapy treatment for Hodgkin’s lymphoma shares a first-person account
of the continued fight against cancer.
Seymour Gendelman, M.D. ’64, who has directed the Mount
Sinai neurology residency program for the past 15 years, was
named Professor Emeritus, Department of Neurology, Mount
Sinai Medical Center in New York City upon his retirement on
Jan. 1, 2015. Gendelman is a lifetime member of the World
Federation of Hemophilia. He has written many papers relating
to the neurologic complications of hemophilia. In his free time,
Gendelman trained for and ran the New York City Marathon.

Creating a
Meaningful Legacy at GW is
easy.
If you have a retirement plan, it’s easy to help deserving students receive a world-class
medical education. You can name the GW School of Medicine and Health Sciences
as a beneficiary of some or all of the funds that may remain in your IRA, 401(k),
or other plan after your lifetime. Just complete a new beneficiary designation form
that includes the GW School of Medicine and Health Sciences and its Tax ID number
(53-0196584) and submit it to your plan administrator.

“As I enjoy retirement, I continue to

reflect on GW - the place where it all
started. Through my estate planning,
I’m doing my part to ensure that the
dream I lived can be realized by others
in the future.” – George Ellis, MD ‘56

Dr. Ellis is supporting the GW School of Medicine
and Health Sciences with a gift of $100,000 through
his IRA. His estate will receive a significant tax
deduction and GW will receive the designated
portion of his IRA tax-free.

A few of the benefits:
Flexibility to support the SMHS program of your choice.
No change in lifestyle since your gift comes from leftover funds.
Elimination of income and estate taxes that otherwise would be due.

We can answer your questions to
help make it even easier. Contact us today!
CALL: 877-498-7590
EMAIL: pgiving1@gwu.edu
ONLINE: go.gwu.edu/plannedgiving
DAR2106

1970s

Culley Carson III, M.D. ’71, FACS, Rhodes Distinguished
Professor of Urology and former chief of urology at the
University of North Carolina at Chapel Hill, received the
2014 St. Paul’s Medal from the British Association of Urologic
Surgeons. Carson also received the 2015 Massachusetts
Medical Society Men’s Health Award during the society’s
13th Annual Symposium on Men’s Health.
Dennis Michael Dimitri, M.D. ’79, vice chair and clinical associate professor of family medicine and community health,
University of Massachusetts Memorial Medical Center, was
elected president of the Massachusetts Medical Society.

1980s

Lisa Murray, M.D. ’86, RESD ’87, was promoted to medical
director at the student health center at Towson University in
Maryland. Previously, she served as physician and medical
staff coordinator for the 22,000-student public university.

1990s

Nicole DeIorio, M.D. ’96, RESD ’00, was recently promoted
to professor of emergency medicine and assistant dean of
student affairs for the Oregon Health and Science University
School of Medicine. Delorio, who also serves as director of
medical student education in the Department of Emergency
Medicine, will serve as a member of the undergraduate
medical education leadership team and will be integral to
supporting all students in the M.D. program.
Leesa M. Galatz, M.D. ’93, RESD ’04, an expert in surgery
for traumatic and degenerative disorders of the shoulder
and elbow, was selected to serve as the system chair of
the Department of Orthopaedics at the Icahn School of
Medicine at Mount Sinai.
Dennis Rivenburgh, PA-C ’97, was named program director
of the Anne Arundel Community College/University of
Maryland-Baltimore Physician Assistant Program.

2000s

Lindsay Marsh Warren, M.D. ’02, RESD ’06, B.A. ’98,
received the GW Black Alumni Association’s 2015 IMPACT
Award on Sept. 26. The honor, entering its 10th year, is the
highest form of recognition bestowed on distinguished
black alumni at the university.
Nihar Patel, M.D., RESD ’08, a hematology
and oncology specialist, recently joined the medical staff at
Willis-Knighton Cancer Center and Hematology/Oncology
Associates. Patel completed a residency and fellowship in
medical oncology and hematology at SMHS.

IN MEMORIAM
Floyd D. Loop, M.D. ’62, RESD
’68, a world-renowned heart
surgeon, former chair and
CEO of the Cleveland Clinic,
passed away in June 2015 at
the age of 78. Loop, whose
initiation into medicine traced
back to his father’s practice in
rural Indiana, graduated from
Purdue University in 1958 and
GW in 1962. He served in the United States Air Force before
training in cardiothoracic surgery at the Cleveland Clinic on
the advice of Brian Blades, M.D., a former Lewis B. Saltz Chair
of Surgery at GW. “That was a defining moment,” Loop told
Medicine + Health in 2013 of his decision to participate in the
clinic’s cardiac program. There, Loop performed thousands
of heart surgeries and assembled a team of thoracic and
cardiovascular surgeons, who elevated the clinic’s reputation
and helped pioneer surgical techniques and innovations.
After accepting a staff position in 1970, Loop became chair
of cardiothoracic surgery at the Cleveland Clinic in 1975. During
his tenure, he crafted the clinic into a profitable top hospital for
heart surgery and expanded its footprint, constructing ambulatory facilities across the state and an additional medical center
in Florida. Loop was responsible for improving preoperative
techniques, arterial grafting, and valve repair, and he helped
launch a computerized registry of cardiac surgery results.
Loop, who retired from surgery in 1999, received
numerous awards and honors, including the American
College of Cardiology Cummings Humanitarian Award, the
American Heart Association Citation for International Service,
and the Cleveland Clinic Lerner Humanitarian Award.
Associate Clinical Professor Emeritus of Medicine Warren
Daniel Brill, M.D., passed away Sept. 14, 2015, at age 94.
A native Washingtonian and graduate of Central High
School and the University of Maryland, where he earned his
Bachelor of Science and Doctor of Medicine degrees in 1941
and 1943 respectively, Brill practiced internal medicine in
Washington, D.C. for 45 years. He served as a professor of
medicine at GW’s School of Medicine and Health Sciences
for more than 30 years, and after his retirement he continued
to guide GW M.D. program students as a volunteer,
teaching patient history and physical examination. He was
a past president of the D.C. Medical Society, a member of
the Jacobi Medical Society, and a fellow of the American
College of Physicians. Brill is survived by his wife of 70 years,
Bess, and their three children, eight grandchildren, and two
great-grandchildren.
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Judson G. Randolph, M.D.,
renowned GW School
of Medicine and Health
Sciences (SMHS)
professor and nationally recognized leader
in pediatric surgery,
passed away on May
17, 2015, in Nashville,
Tennessee, at the age
of 87. Randolph was
born July 9, 1927, in
Macon, Georgia, and
grew up in Nashville. After serving in the Navy from 1945
to 1946, Randolph returned to his hometown to attend
Vanderbilt University; he graduated from the school in 1950
and earned his medical degree from Vanderbilt’s medical
school in 1953.
Before joining the GW faculty as a professor of
surgery and pediatrics in 1963, he trained in surgery at
Massachusetts General Hospital and Boston Children’s
Hospital. He was also a faculty member at Harvard Medical

Ozgur Ekmekci, Ed.D., M.B.A., faculty
member in GW’s School of Medicine
and Health Sciences Department of
Clinical Research and Leadership since
2007, passed away Sept. 19, 2015,
following a heart attack.
Ekmekci, an associate professor of
clinical research and leadership, served
as the interim chair of the department
from 2013 to 2015. Under his leadership, the department grew to offer
nearly a dozen programs in addition
to many military contract specialty
programs. He served as the program
director for the Health Care Quality
Master’s Degree Program from 2007
to 2013, where he provided strategic
leadership in an area of significant
growth.
During his time as a leader in the
health sciences, Ekmekci continued
to conduct research in and teach
graduate-level courses in leadership,
organizational change, health information technology, health care quality,
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School. The year he arrived at GW, Randolph started his
25-year tenure as surgeon-in-chief at what is now Children’s
National Health System (Children’s National).
“Dr. Randolph was one of the giants of American
surgery,” said Anton Sidawy, M.D., M.P.H., Lewis B. Saltz
Chair of the Department of Surgery and professor of surgery
at SMHS. “He trained over 40 fellows in pediatric surgery,
many of whom assumed leadership positions in prestigious
institutions around the country. In addition, he introduced
hundreds of surgical residents to pediatric surgery and
inspired them to pursue academic careers of their own; I
was one of those residents. He was a spectacular surgeon, a
dedicated mentor, and a passionate leader who always put
his patients first. He will certainly be missed by his friends,
colleagues, and trainees.”
Among his many accomplishments, Randolph was
a former chair of the surgical section of the American
Academy of Pediatrics, president of the American Pediatric
Surgical Association, and founder of the American Board of
Surgery’s pediatric committee. Following his retirement from
Children’s National, the Judson G. Randolph Fellowship in
Pediatric Surgery was established in his honor.

learning evaluation, and research
methods. His research interests
centered on interprofessional education (IPE), organizational identification,
professional identity, and agent-based
modeling. Ekmekci had recently
completed a yearlong study to develop
a method to evaluate learning and
performance in IPE teams. The project
built upon an earlier study on IPE,
published in 2013 in the Journal of the
Allied Health Professions, that showed
a “significant increase in teamwork and
leadership” after executive coaching
and simulation.
Senior Associate Dean for Health
Sciences Joe Bocchino, Ed.D., M.B.A.,
described Ekmekci as a “remarkable person, a wonderful friend, an
outstanding teacher, and a terrific
member of the faculty. As a testament
to the high regard that his colleagues
and students had for him, Ekmekci
was awarded the university’s Bender
Teaching Award in 2011.”

William V. Applegate, M.D. ’57
Frank Thomas Barranco Sr., M.D. ’56
Jeanne Barinott Bradley, M.D. ’51,
RESD ’52
John Grover Bradley, M.D. ’51, RESD ’52
Milton H. Brinton, M.D. ’77
Richard Carlisle, M.D. ’65
Sheridan L. Daines, M.D. ’65
Eugene Chester Dolphin, B.S. ’77
Pamela F. Farrington, M.D., RESD ’86
Arland K. Faust, M.D. ’59
C. Richard Gill, M.D. ’55
Ebrahim Navid, M.D., RESD ’67
Joseph E. Rawlings, M.D. ’53, B.A. ’50
Jerome V. Rose, M.D. ’45
Jimmy Lynn Stubblefield, PA ’99

IN DEVELOPMENT

Dean’s Council Members
Stuart S. Kassan, M.D. ’72, FACP, MACR, Co-Chair
Rheumatology; Distinguished Clinical Professor of Medicine,
University of Colorado-Denver School of Medicine; Chief Medical
Officer, Multispecialty Physician Partners; GW Board of Trustees
Lara S. Oboler, M.D. ’95, Co-Chair
Cardiology; Lenox Hill Heart & Vascular Institute
Gary M. Abramson
Partner, the Tower Companies
Christopher L. Barley, M.D. ’93
Internal Medicine; Clinical Assistant Professor of Medicine, Cornell/
Weill School of Medicine
Luther W. Brady Jr., M.D. ’48, HON. ’04, B.A. ’46
Radiation Oncology; Professor, Department of Radiation Oncology,
Drexel University College of Medicine; GW Emeritus Trustee
Carlos R. Diaz, M.D. ’72, RESD ’75
Internal Medicine; Head, Internal Medicine Department, Naval
Aerospace Medical Institute
Daniel Ein, M.D., FACP, FAAAAI, FACAAI
Allergy, Asthma, and Immunology; Clinical Professor of Medicine,
The George Washington University School of Medicine and Health
Sciences (SMHS); Director, Allergy and Sinus Center, GW Medical
Faculty Associates

B

ecause academic medicine makes a profound impact
on the quality of life and the state of knowledge, it
historically has attracted significant philanthropic
gifts. That continues today as medical schools and
teaching hospitals in the United States have received newsworthy seven- and eight-figure gifts in 2015. There have even
been incredible nine-figure commitments, for instance, to the
Memorial Sloan Kettering Cancer Center.
Often these gifts come from the hands of grateful patients
or their families, from regional business leaders or alumni.
Always the gifts come because of the demonstrable excellence
of the results, innovation, and vision embodied in the recipient.
Great programs, great ideas, and great people attract great
philanthropy.
Cancer, neuroscience, and transplantation, three of GW’s
rapidly expanding areas of clinical and research innovation, are
highlighted in this issue of Medicine + Health. Will one of them
inspire a visionary benefactor to emerge and make a magnificent gift to the School of Medicine and Health Sciences? Now
is the opportune time, because our physicians, scientists, and
professional staff are ready to make history as never before.
Sincerely,

Dennis Narango, M.A., C.F.R.E.
Associate Dean, SMHS and Associate Vice President for GW
Medicine Development and Alumni Relations

Thomas E. Flynn, M.D. ’86
Ophthalmology; Owner, Ellsworth, Uvetis, & Retina Care
Jeanne G. Holzgrefe, M.D. ’96, PH.D., M.P.H.
Psychiatry; Chevy Chase Psychiatric Services; Assistant Clinical
Professor of Psychiatry and Behavioral Sciences, SMHS
Floyd Alexander Katske, M.D. ’76, RESD ’77
Urology; Clinical Assistant Professor of Urology, David Geffen
School of Medicine, University of California–Los Angeles
Jay E. Katzen, M.D. ’72, B.A. ’67
Ophthalmology; The Eye Center; GW Board of Trustees
Kerry L. Kuhn, M.D. ’73, RESD ’77, B.A. ’70, FACOG
OB/GYN; Private Practice; Senior Vice President of VitalMD
Gerald S. Lazarus, M.D. ’63
Dermatology; Professor of Dermatology, Johns Hopkins University;
Former Member, GW Board of Trustees
John C. Pan, M.D. ’70, RESD ’74
OB/GYN; Founder, Center for Integrative Medicine, SMHS
Smita H. Patel, M.B.B.S., DFAPA
Psychiatry; Assistant Clinical Professor of Psychiatry and Behavioral
Sciences, SMHS; Private Practice
Richard G. Popiel, M.D. ’81, RESD ’83, M.B.A., B.S. ’75
Internal Medicine; Executive Vice President, Healthcare Services
and Chief Medical Officer, Cambia Health Solutions and Regence
Health Insurance Company
Rakesh C. Sahni, M.D.
Cardiology; Maryland Cardiology Associates
Mark W. Surrey, M.D. ’72, FACOG, FACS
OB/GYN-Fertility; Professor and Clinical Director, Reproductive
Surgery, University of California-Los Angeles; Co-Founder and
Medical Director, Southern California Reproductive Center
Allan B. Weingold, M.D., HON. ’98
OB/GYN; Professor Emeritus, Former Chair of OB/GYN, Former Vice
President for Medical Affairs and Executive Dean, SMHS
Art B. Wong, M.D. ’67
Emergency Medicine; Founder, Emergency Physicians Medical
Group, PC
The Dean’s Council advises the dean of the School of Medicine and Health Sciences on strategic
priorities and important issues for the school, and provides generous support and advocacy.

NON-PROFIT ORG.
U.S. POSTAGE
PAID
KENT, OH
PERMIT NO. 15

OFFICE OF COMMUNICATIONS AND MARKETING

2030 M St., N.W.
Suite 4024
Washington, D.C. 20036

A COMPREHENSIVE CANCER VISIONARY
Renowned lymphoma researcher Eduardo Sotomayor, M.D., Ph.D., came to GW’s School of Medicine
and Health Sciences for one purpose: to build a premier cancer center that excels in research, clinical
investigations, prevention/control policy, and patient education and outreach. Read more on page 14.

